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SUMMARY 
English summary 
Background: Atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical 
practice, and its prevalence is expected to further increase in the future. AF patients 
not only have a high number of comorbidities, but they also have an increased risk of 
hospital admissions compared to individuals without AF. Nevertheless, predicting 
hospital admission risk among patients with AF remains difficult, and possible 
preventive strategies unclear.  
Based on these gaps in knowledge, the overall goal of this PhD thesis was to 
investigate the incidence of and causes for all-cause hospital admission in patients 
with AF. The specific aims were (1) to perform a systematic review and meta-analysis 
summarizing the current evidence of the incidence of and associated risk factors for 
hospital admissions in AF patients; (2) to identify risk factors for hospital admissions in 
our own cohorts and subsequently use this knowledge to develop and validate a risk 
score for predicting hospital admissions; (3) to identify psychosocial factors associated 
with hospital admissions in patients with AF.  
Methods: For the meta-analysis, we performed a comprehensive literature search in 
PubMed, EMBASE and CENTRAL, and pooled incidence rates for hospital admissions 
using random-effects models. Factors associated with observed between-study 
heterogeneity were identified using meta-regression analysis.  
For the second and third study, we used data of two ongoing, prospective observational 
cohort studies, the Basel Atrial Fibrillation Cohort Study (BEAT-AF) and the Swiss 
Atrial Fibrillation Cohort Study (Swiss-AF) in which 3,968 patients with diagnosed AF 
were enrolled. Unplanned hospital admissions were defined as any unpredicted 
admission leading to at least one overnight stay. For the second study, we used the 
Swiss-AF data set as the derivation cohort and performed a variable selection using 
the least absolute shrinkage and selection operator (LASSO) method. Multivariable 
adjusted Cox regression analyses were performed to assess the effect of the selected 
variables on all-cause hospitalization. Based on regression coefficients we constructed 
a risk score and subsequently validated the score in the external validation cohort 
(BEAT-AF).  
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For the third study, we used psychosocial factors, such as marital status, education, 
level of depression and health perception, and investigated their effects on risk of 
hospital admission. Cox regression analyses adjusted for conventional risk factors for 
hospital admission were performed to calculate hazard ratio (HR).  
Results: We included 35 studies of 311’314 AF patients in the meta-analysis. The 
pooled incidence of all-cause hospital admissions was 43.7 per 100 person-years. AF 
patients were more often admitted for cardiovascular causes (26.3 per 100 person-
years), but the risk of non-cardiovascular hospitalizations was substantial (15.7 per 
100 person-years). Associated factors for hospital admission were older age, longer 
follow-up time and prevalent chronic pulmonary disease or cancer.  
In the second study we found that the most important predictors for all-cause hospital 
admission were age (75-79 years: adjusted hazard ratio [aHR], 1.33; 95% confidence 
interval [95% CI], 1.00-1.77; 80-84 years: aHR, 1.51; 95% CI, 1.12-2.03; ≥85 years: 
aHR, 1.88; 95% CI, 1.35-2.61), prior pulmonary vein isolation (aHR, 0.74; 95% CI, 
0.60-0.90), hypertension (aHR, 1.16; 95% CI, 0.99-1.36), diabetes (aHR, 1.38; 95% 
CI, 1.17-1.62), coronary heart disease (aHR, 1.18; 95% CI, 1.02-1.37), prior stroke/TIA 
(aHR, 1.28; 95% CI, 1.10-1.50), heart failure (aHR, 1.21; 95% CI, 1.04-1.41), 
peripheral artery disease (aHR, 1.31; 95% CI, 1.06-1.63), cancer (aHR, 1.33; 95% CI, 
1.13-1.57), renal failure (aHR, 1.18, 95% CI, 1.01-1.38), and previous falls (aHR, 1.44; 
95% CI, 1.16-1.78). A risk score with these variables was well calibrated, and achieved 
a C statistic of 0.64 (95% CI, 0.61-0.66) in the derivation and 0.59 (95% CI, 0.56-0.63) 
in the external validation cohort.  
In the third study including patients from Swiss-AF, 1582 (67.1%) were married, 156 
(6.6%) were single, 287 (12.2%) were divorced, and 333 (14.1%) were widowed. Two 
hundred and seventy six patients (11.7%) had at most a primary education, 1171 (49.7) 
had secondary education, and 911 (38.6%) had a college or university degree. 
Depression or depressive symptoms was present in 99 (4.2%) patients. Median health 
perception was 75 (interquartile range [IQR], 60-85) on a scale ranging from 0-100, 
with higher scores indicated better health perception. The highest risk of all-cause 
hospital admission was observed in single (aHR, 1.35; 95% CI, 1.05-1.75) or divorced 
patients (aHR, 1.26; 95% CI, 1.03-1.54), and in those who reported low health 
perception (aHR for <75 points, 1.40; 95% CI, 1.21-1.61).  
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Conclusions: The overall incidence of hospital admissions in patients with AF is high. 
The risk of hospital admissions is related to multiple cardiovascular and non-
cardiovascular risk factors, including several psychosocial factors and subjective 
health perception.  
Outlook: Given the high risk among AF patients of being admitted to the hospital and 
the high burden of associated risk factors, new multidisciplinary preventive strategies 
are needed with the goal to reduce hospital admissions, unfavorable patient 
outcomes and healthcare costs. 
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ZUSAMMENFASSUNG 
Hintergrund: Vorhofflimmern (VHF) gilt als die häufigste Herzrhythmusstörung in der 
Allgemeinbevölkerung mit ansteigender Prävalenz. Es konnte gezeigt werden, dass 
Patienten mit VHF nicht nur eine hohe Anzahl an Komorbiditäten aufweisen, sondern 
im Vergleich zu Individuen ohne VHF, auch ein erhöhtes Risiko haben, in ein Spital 
eingeliefert zu werden. Nichtsdestotrotz, die Vorhersage von Hospitalisationen bei 
VHF Patienten bleibt schwierig und es gibt aktuell keine Präventionsstrategien. 
Basierend auf diesen Wissenslücken, war es das Ziel dieser PhD Dissertation, das 
Auftreten und die Ursachen der Hospitalisationen bei Patienten mit VHF zu erforschen. 
Die spezifischen Ziele waren (1) einen systematischen Überblick und eine 
Metaanalyse zur aktuellen Literatur, bezüglich der Inzidenz und den assoziierten 
Risikofaktoren von Hospitalisationen bei VHF Patienten zu erstellen; (2) in unseren 
eigenen VHF Kohortenstudien herauszufinden, welches die Risikofaktoren für 
Hospitalisationen sind und anschliessend einen Risikoscore für die Prädiktion von 
Hospitalisationen zu erarbeiten; (3) die psychosozialen Faktoren zu finden, welche mit 
einem erhöhten Risiko für Hospitalisationen bei VHF Patienten einhergehen könnten. 
Methoden: Für die Metaanalyse führten wir eine ausführliche Literaturrecherche in 
den drei bekannten Online Datenbanken PubMed, EMBASE und CENTRAL durch und 
fassten die Inzidenz von Hospitalisationen mit Hilfe von Random-Effects Modellen 
zusammen. Faktoren, welche mit der beobachteten Heterogenität assoziiert sein 
könnten, wurden mittels Metaregression Analysen untersucht.  
Für die zweite und dritte Arbeit konnten wir die Daten zweier laufenden prospektiven 
Observationsstudien, die Swiss Atrial Fibrillation Cohort Study (Swiss-AF) und die 
Basel Atrial Fibrillation Cohort Study (BEAT-AF), mit insgesamt 3968 
eingeschlossenen diagnostizierten VHF Patienten verwenden. Ungeplante 
Hospitalisationen wurden definiert als jede Hospitalisation, welche zu einer 
Übernachtung im Spital führte. Für die zweite Arbeit nutzten wir Daten der Swiss-AF 
Studie als Kohorte für die Entwicklung des Risikoscores und führten eine 
Variablenselektion mittels least absolute shrinkage and selection operator (LASSO) 
durch. Multivariat-adjustierte Cox Regressionsanalysen wurden durchgeführt, um den 
Effekt von den selektionierten Variablen auf die Hospitalisationen zu untersuchen. 
Mittels der Regressionskoeffizienten haben wir einen Risikoscore aufgebaut und 
diesen in der externen Kohorte (BEAT-AF) validiert. Für die dritte Arbeit untersuchten 
13 
 
wir psychosoziale Faktoren wie Zivilstand, Schulbildung, Depression und subjektive 
Gesundheitswahrnehmung und deren Auswirkung auf das Auftreten von 
Hospitalisationen. Um Hazard Ratios (HR) zu berechnen, wurden für konventionelle 
Risikofaktoren Cox Regressionsanalysen durchgeführt und adjustiert für Variablen, 
welche in der zweiten Arbeit als Prädiktoren für Hospitalisationen hervorgingen.  
Resultate: Wir haben 35 Studien mit insgesamt 311'314 VHF Patienten in die 
Metaanalyse eingeschlossen und fanden eine zusammengeführte Inzidenz der 
gesamten Hospitalisationen von 43.7 pro 100 Personenjahren. VHF Patienten wurden 
häufiger wegen kardiovaskulärer Ursachen hospitalisiert (26.3 pro 100 
Personenjahren), aber das Risiko für nicht-kardiovaskuläre Hospitalisationen war 
beträchtlich (15.7 pro 100 Personenjahren). Assoziierte Risikofaktoren für 
Hospitalisationen waren: höheres Alter, längere Beobachtungszeit, erhöhte Prävalenz 
von chronisch obstruktiver Lungenkrankheit (COPD) und vermehrtes Auftreten von 
Karzinomen.  
In der zweiten Arbeit waren die wichtigsten Prädiktoren für Hospitalisationen das Alter 
(75-79 Jahren: adjustierte HR, 1.33; 95% Konfidenzintervall [95% KI], 1.00-1.77; 80-
84 Jahren: aHR, 1.51; 95% KI, 1.12-2.03; ≥85 Jahren: aHR, 1.88; 95% KI, 1.35-2.61)), 
vorherige Pulmonalvenenisolation (aHR, 0.74; 95% KI, 0.60-0.90), Hypertonie (aHR, 
1.16; 95% KI, 0.99-1.36), Diabetes (aHR, 1.38; 95% KI, 1.17-1.62), koronare 
Herzkrankheit (aHR, 1.18; 95% KI, 1.02-1.37), gehabter Schlaganfall (aHR, 1.28; 95% 
KI, 1.10-1.50), Herzinsuffizienz (aHR, 1.21; 95% KI, 1.04-1.41), periphere arterielle 
Verschlusskrankheit (aHR, 1.31; 95% KI, 1.06-1.63), Karzinom (aHR, 1.33; 95% KI, 
1.13-1.57), Niereninsuffizienz (aHR, 1.18, 95% KI, 1.01-1.38) und Stürze (aHR, 1.44; 
95% KI, 1.16-1.78). Einen Risikoscore mit diesen Variablen war gut kalibriert und 
erreichte eine C Statistik von 0.64 (95% KI, 0.61-0.66) in der Entwicklungskohorte und 
0.59 (95% KI, 0.56-0.63) in der Validierungskohorte.  
In der dritten Arbeit verwendeten wir ausschliesslich Patientendaten von Swiss-AF. 
Davon waren 1582 (67.1%) verheiratet, 156 (6.6%) alleinstehend, 287 (12.2%) 
geschieden, und 333 (14.1%) verwitwet. Zweihundertsechsundsiebzig Patienten 
(11.7%) verfügten über eine Grundschulbildung oder weniger, 1171 (49.7) über eine 
Sekundarschulbildung und 911 (38.6%) hatten eine Fachhochschule oder eine 
Universität besucht. Depressionen resp. depressive Symptome hatten 99 (4.2%) 
Patienten. Der Median der subjektiven Gesundheitswahrnehmung war 75 
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(Interquartilsabstand, 60-85) auf einer Skala von 1-100, wobei ein höherer Score eine 
bessere Gesundheitswahrnehmung darstellt. Das höchste Risiko für Hospitalisationen 
zeigten Patienten, welche alleinstehend (aHR, 1.35; 95% KI, 1.05-1.75) oder 
geschieden waren (aHR, 1.26; 95% KI, 1.03-1.54) und solche, welche eine subjektiv 
schlechtere Gesundheitswahrnehmung hatten (aHR für <75 Punkten, 1.40; 95% KI, 
1.21-1.61). Für kardiovaskuläre und nicht-kardiovaskuläre Hospitalisationen war nur 
eine subjektiv schlechtere Gesundheitswahrnehmung ein starker Prädiktor.  
Schlussfolgerungen: Die Gesamtinzidenz der Hospitalisationen von Patienten mit 
VHF ist hoch. Das Risiko für Hospitalisationen ist assoziiert mit multiplen 
kardiovaskulären und nicht-kardiovaskulären Risikofaktoren, inklusive psychosozialen 
Faktoren. 
Ausblick: Angesichts des hohen Risikos von VHF Patienten hospitalisiert zu werden 
und der hohen Anzahl an assoziierten Risikofaktoren, sind neue Präventionsstrategien 
erforderlich mit dem Ziel die Hospitalisationsraten zu verringern, ungünstige 
Patientenergebnisse zu verhindern und Gesundheitskosten zu reduzieren. 
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1. BACKGROUND 
1.1. Atrial fibrillation – risk factors and health consequences 
1.1.1. Epidemiology of atrial fibrillation 
Since its first ECG documentation by Willem Einthoven1, atrial fibrillation (AF) has 
become the most prevalent cardiac arrhythmia, occurring in approximately 1-2% of the 
general population.2,3 In the European Union and worldwide, the number of patients 
with AF is expected to increase substantially in the coming decades and may even 
double in the period from 2010 to 2060 (Figure 1).4,5 The progressive increase of the 
incidence, prevalence and mortality associated with AF is expanding globally, with 
enormous consequences on healthcare systems and societies. 
1.1.2. Risk factors for atrial fibrillation 
Several established risk factors are associated with the risk for the development of AF. 
The Framingham Heart Study identified various predictors for incident AF, including 
advanced age, hypertension, presence of heart failure or coronary heart disease, 
diabetes mellitus and valvular heart disease (i.e. mitral valve stenosis).6 It has been 
shown that there seems to be an exponential association between advancing age and 
risk of new-onset AF, resulting in a lifetime risk of approximately 25%.7 Beyond age, 
the most important risk factor for incident AF is heart failure. Depending on the data, 
Figure 1 Projected number of persons with AF in the United States between 2000 and 
2050, assuming no further increase in age-adjusted AF incidence (solid curve) and 
assuming a continued increase in incidence rate as evident in 1980 to 2000 (dotted 
curve) (Miyasaka et al., Circulation 2006). 
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the incidence of AF among patients with diagnosed heart failure has been estimated 
to be 5.4 per 100 person-years.8 In addition, the odds of developing AF in patients with 
preexisting heart failure has been estimated 6.1 in men and even higher in women with 
8.1.6 B-type natriuretic peptide (BNP), a vasoactive peptide predominantly secreted by 
cardiomyocytes, is a well-established biomarker for heart failure and has been 
associated with incident AF, further underscoring this important interrelationship.9 
Hypertension is one of the major risk factors for AF. Data from the Framingham Heart 
Study suggest that hypertension defined as a systolic blood pressure of at least 160 
mmHg or a diastolic blood pressure of at least 95 mmHg is significantly associated with 
the risk of developing AF with odds ratio (OR) of 1.6 (95% CI, 1.2-2.2) in men and 1.7 
(95% CI, 1.2-2.4) in women.6 Consistent with these observations, data from the 
Atherosclerosis Risk in Communities (ARIC) Study suggest that elevated blood 
pressure was the largest contributor to the overall risk of AF, with an estimated 
population attributable fraction of 21.6%.10 Apart from hypertension, evidence has 
accumulated that obesity is an independent risk factor for AF development.11 Patients 
who were overweight or obese (body-mas index [BMI] ≥25-29 kg/m2 or ≥30kg/m2) has 
been estimated to account for 18% and 12% in patients with elevated BMI. It has been 
proposed that obesity and elevated body-fat percentage predispose left atrial 
enlargement and ventricular diastolic dysfunction, both are predictors of AF.12 Heavy 
alcohol consumption has long been known as a risk factor for incident AF and has 
recently been associated to the proposed so-called “holiday heart syndrome.” Several 
prospective cohort studies have investigated the association of moderate to high 
alcohol consumption and incident AF. In the Framingham Heart Study, participants 
who consumed high amounts of alcohol (>36 g/day) had a significantly higher risk of 
incident AF.13 Women who consumed ≥2 drinks/day also showed a higher risk of 
developing AF.14 Nonetheless, a meta-analysis showed a linear dose-response 
relationship between alcohol consumption and the risk of developing AF, even 
moderate alcohol consumption, which has been proposed to be protective for other 
cardiovascular diseases, seems to increase the risk of AF.15  
1.1.3. Health consequences of atrial fibrillation 
The public health impact of AF is further underscored by an increased risk of stroke, 
congestive heart failure and death.8,16-18 Also, AF is associated with a poor quality of 
life and was suggested to decrease cognitive function compared to individuals without 
AF.19-21 Finally, AF also accounts for one-third of hospital admissions for cardiac 
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rhythm disturbances, and the rate of hospital admissions has risen in recent years.22 
Many studies have shown that AF patients have a high burden of cardiovascular co-
morbidities.23-25 For example, Caroll et al. showed that ischemic heart disease, heart 
failure and hypertension were the most common comorbidities associated with AF.26 
Another recent study demonstrated that a substantial number of patients with AF were 
also diagnosed with at least one other cardiovascular comorbidity. The investigators 
also found that comorbidities in AF patients extended far into other organ systems 
including urologic, respiratory and gastrointestinal disorders.25 Consequently, patients 
with AF have a high risk of complications and adverse outcome events.27 
Stroke 
The most clinically important complication is the formation of cardiac thrombus in the 
atria and systemic embolization leading to strokes. A meta-analysis showed that the 
relative risk of stroke is 2.4 and the absolute risk is 3.6 per 1000 person-years follow-
up.27 Data from contemporary studies indicate that 20-30% of all ischemic strokes is 
accountable to AF and stroke risk increases by 5-fold with diagnosis of AF.18 Oral 
anticoagulation has shown to be highly effective for stroke prevention, by reducing the 
absolute risk of stroke.28 Also, patients with device-detected subclinical AF are at risk 
for stroke, whereas the absolute risk has been estimated lower compared to patients 
with diagnosed AF.29 Whether these patients also benefit from oral anticoagulation is 
currently being investigated.30 
Heart failure 
Heart failure is not only a risk factor for developing AF, but also constitutes as an 
important consequence of AF. They often occur together, have similar underlying risk 
factors, and their combination strongly correlates with increased morbidity and 
mortality.8,31,32 The pathophysiological interrelationship between AF and heart failure 
has been intensively investigated. It has been suggested that AF may facilitate the 
development and progression of heart failure thorough several different ways.33 
Through the irregular exaggerated heart rate results in a shorter diastolic filling time, 
which as a consequence may result in reduced cardiac output. Furthermore, the 
irregular contractions of the atria contributes to the development of diastolic 
dysfunction and subsequently heart failure. Although there seems to be a strong 
interrelationship between those two disorders, it remains unclear whether AF is a risk 
factor for heart failure or a just marker of advanced heart failure disease. 
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Death 
Given the chronic nature of disease, AF has been independently associated with 
morbidity and mortality.16 In 2 population-based cohorts, patients who had incident AF 
had a 2.5-fold increased risk of sudden cardiac death and a 3-fold increased risk of 
non-sudden cardiac death.34 Data from the Randomized Evaluation of Long-Term 
Anticoagulation Therapy (RELY) trial suggest that AF patients treated with oral 
anticoagulation, sudden cardiac death accounts for more than 20% of all deaths.35 
Furthermore, an analysis from the Effective Anticoagulation with Factor Xa Next 
Generation in Atrial Fibrillation–Thrombolysis In Myocardial Infarction 48 (ENGAGE 
AF-TIMI 48) trial where AF patients were randomized to receive either edoxaban, an 
oral factor Xa inhibitor, or warfarin showed that over 90% of all sudden cardiac deaths 
occurred out of the hospital.36 Among a population of healthy women, new-onset AF 
was also strongly associated with all-cause and cardiovascular death.17 The absolute 
risk for non-cardiovascular death was higher than for cardiovascular deaths (6.5 vs. 
4.3 per 1000 person-years of follow-up).  
Cognitive dysfunction 
Cognitive decline is strongly related to morbidity, leading to disability and subsequently 
death.37,38 Management of dementia syndromes has been recognized as a public 
health priority.39 Also, the consequences of cognitive decline and dementia are a major 
driver of health care costs.40 More recent evidence suggests that patients with AF have 
increased risk of cognitive dysfunction and incident dementia. Clinically unrecognized 
(silent) cerebral infarcts may explain this association. Longitudinal data from the 
Rotterdam Scan Study including elderly people without AF have shown that individuals 
with silent brain infarcts have an increased risk of dementia and a steeper decline in 
cognitive function than those without such lesions.41 This finding has recently been 
confirmed in a meta-analysis of patients without AF, with a pooled 1.3-fold increased 
risk for incident dementia.42 Among patients with established AF, a recent study 
showed that these patients not only have a high burden of vascular brain lesions, such 
as silent infarcts, white matter lesions and microbleeds, but also that the burden of 
silent brain lesions was associated with cognitive dysfunction.43 Although there is 
growing awareness about the relationship between AF and dementia, there is currently 
no screening strategy or intervention available, with most recommendations being 
moderate due to lack of evidence.44  
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1.2. Atrial fibrillation – risk of hospital admissions 
1.2.1. Incidence rate of hospital admissions 
Over the past decades evidence has accumulated suggesting that hospital admission 
rates in patients with AF are increasing exponentially worldwide, and recent data 
indicate that these rates may increase in the near future.45-47 The clinical view has 
especially shifted to unplanned hospital admissions. In an emergency department 
setting for example, the population-adjusted rates of admission of patients with AF 
have been estimated to have increased from 0.6 to 1.2 per 1000 person-years of 
follow-up.48 Indeed this rise in admission rates may be in part due to the aging of the 
general population, and also because of the increasing prevalence of conventional 
cardiovascular risk factors such as hypertension, diabetes and obesity. Current 
thinking indicates that the rates of hospital admission among AF patients will 
substantially rise in the near future which would pose a huge burden on our societies 
given the increase in health care expenditures associated with this event. Yet there 
remains a wide range of uncertainty on the actual risk of hospital admission and the 
underlying factors associated with this outcome in patients with AF. 
Figure 2 Kaplan-Meier rates of first hospital admission, by cause (Steinberg et al., Am Heart J 
2014). 
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Data from the United States show that the trends of hospital admissions from 2000 to 
2010 in AF patients have been continuously increasing.47 When we look at data from 
the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) 
study, a prospective multicenter outpatient registry of AF patients who were enrolled 
across the United States, the investigators estimated that nearly 1 in 3 patients were 
hospitalized within one year of follow-up (Figure 2).49 In addition, those patients who 
were frequently admitted, had a higher risk of all-cause death. In this study the 
investigators found clinical predictors that were associated with the risk of admission 
such as elevated heart rate measured at baseline visit, increased AF symptom burden 
and coexisting heart failure. Apart from these significant predictors, AF type defined as 
paroxysmal, persistent or permanent was not associated with hospital admission. 
Nevertheless, evidence is still lacking on the long-term prognostic trend for hospital 
admissions in patients with AF mainly due to the short follow-up duration of 12 months 
in most studies. Detailed risk assessment in these patients was not established in 
ORBIT-AF and is therefore needed to be identified.  
1.2.2. Causes for hospital admissions 
Aside from the admission risk, an important aspect of frequent hospital admissions are 
the underlying causes. In the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition 
Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in 
Atrial Fibrillation trial (ROCKET AF), the investigators sought to identify the main 
reasons for and associated predictors for hospital admission in AF patients.50 They 
found that among this population of outpatients with diagnosed AF, almost 1 of 7 was 
hospitalized within 2 years and half of those admissions were due to cardiovascular 
causes. The primary cardiovascular reasons for admission were heart failure (14%), 
bleeding (12%), stroke (7%), acute coronary syndrome (5%), AF-related disorders 
(4%) and other cardiovascular causes (10%) (Figure 3). Although roughly 50% of all 
admissions were due to cardiovascular causes, both AF and bleeding were rare 
causes for the outcome. In a large sample of patients from the Nationwide 
Readmissions Database (NRD) for the year 2013, investigators evaluated 30-day 
readmission risk after discharge in patients with diagnosed AF.51 They found that the 
most common cause behind readmission was AF (27%), heart failure (11%) and 
ischemic heart disease (3%). Stroke only accounted for 2.5% of all hospital admissions 
within 30 days after discharge. Also in short-term follow-up, stroke admissions were 
relatively uncommon, whereas heart failure was one of the drivers for patients being 
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admitted to the hospital. However, only little information is available about the non-
cardiovascular causes for readmissions.  
In ROCKET AF, the largest proportion of any hospital admission was due to non-
cardiovascular, including diagnoses such as pneumonia, chronic obstructive 
pulmonary disease (COPD), and urinary tract infections. In ORBIT-AF, 43% of all 
admission were due to non-cardiovascular causes. However, the researchers did not 
provide specific reasons for these admissions. In a retrospective study using data from 
the United States Thomson Reuters MarketScan Medicare Supplemental and 
Coordination of Benefits Database showed that patients were more often hospitalized 
for non-cardiovascular than cardiovascular causes during the first year of follow-up. 
The underlying mechanism of non-cardiovascular causes for hospital admission has 
not been fully discussed, although gaining knowledge about these reasons are of 
clinical importance.  
1.2.3. Risk factors for hospital admissions 
Hospital admission is a heterogeneous outcome with many factors associated with this 
event. Probably the most important factors associated with the outcome are presence 
of multiple co-factors, such as pulmonary disorders, diabetes, hypertension and heart 
failure. Studies have shown that the presence of selected comorbid conditions 
correlates with the incidence rate of all-cause hospitalizations.50 Especially the 
presence of COPD, chronic kidney disease (CKD) and heart failure were significantly 
associated with all-cause admission rates (Figure 3). Although a large proportion of 
Figure 3 Reasons for hospital admission during study follow-up. This figure displays the 
reasons for all hospital admissions (N=2614) (DeVore et al., Europace 2016). 
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hospital admissions were attributable to non-cardiovascular causes, information on 
associated risk factors were not provided in this study. Further research is therefore 
needed to determine which risk factors are related to cardiovascular, but also to non-
cardiovascular hospital admissions. Also for 30-day readmission, the strongest 
predictors for this event to occur was the presence of multiple comorbidities.51 This 
suggests that multiple factors are associated with a high admission risk and therefore 
a multi-factorial approach might be useful in reducing those admission rates in this 
specific group of patients.   
1.2.4. Health care costs of hospital admissions 
From a socio-economic point of view, hospital admissions are one of the largest driver 
for health care expenditures worldwide, and costs directly correlate with the number of 
admissions. Data from Denmark indicate that over 50% of all costs and over 70% of 
AF attributable costs are due to hospital admissions.52 A systematic review suggests 
that 50 to 70% of the total annual costs in patients with AF are directly attributable to 
hospital admissions.53 Furthermore, a retrospective observational cohort study that 
used health care MarketScan data showed that direct medical costs are substantially 
higher in AF patients compared to medically matched non-AF controls and that the 
primary cause for this immense difference is due to higher inpatients cost (through 
more frequent hospital admissions).54 This economic burden of AF on health care 
systems is likely to continue to grow in the future. Reducing the need for hospital 
admission is a key factors in controlling the costs. Given this, identifying preventive 
strategies and targets to reduce the risk of AF patients being admitted to the hospital 
should be public health priority. 
Given the high admission rates in this patient population, suggestions for preventive 
strategies are particularly of interest. Implementation of preventive interventions may 
have the potential to assist physicians and care providers in managing acute changes 
in patient clinical status and may reduce unnecessary admissions. The Interventions 
to Reduce Acute Care Transfers (INTERACT) trail examined whether training and 
support for the implementation of a nursing home quality improvement program 
reduces hospital admissions and ED visits.55 The recently published results from this 
trail were rather disappointing, showing no effects on hospitalization or ED visit rates 
in the overall population of residents of participating nursing homes. The Hospital 
Readmissions Reduction Program (HRRP) has recently been proposed as possible 
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intervention to reduce costly readmissions in patients who have been discharged.56 
This program reduces payments to hospitals with excess readmission, and it 
successfully reduced short- and long-term admissions in patients with heart failure, but 
there seems to be a tradeoff with an increase in 30-day and 1-year mortality.57 Also, 
the performance of such interventions has not been examined in large AF populations. 
Thus, there is an unmet need to investigate factors that increase the risk of AF patients 
for being admitted to the hospital, and subsequently use this knowledge to establish 
and implement preventive strategies which may hopefully have an impact on 
admission rates in this highly vulnerable population.  
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2. AIMS AND OBJECTIVES 
The overall, primary aim of this thesis was to investigate the incidence of and risk 
factors associated with hospital admissions in patients with diagnosed AF.  
2.1. Incidence of and causes for hospital admissions in atrial 
fibrillation 
The overall aim of this study was to perform a systematic review and meta-analysis 
assessing the incidence of and causes for hospital admissions in patients with AF.  
Objectives 
1. To perform a systematic review on studies reporting the incidence of hospital 
admission in AF patients. 
2. To pool the overall incidence of all-cause hospital admission in patients with AF. 
3. To compare incidence rates for cardiovascular and non-cardiovascular hospital 
admissions in AF patients. 
4. To investigate the causes for hospital admissions in patients with AF. 
Specific research questions 
1. How often are patients with AF hospitalized and what is their overall risk? 
2. What are the causes for hospital admissions in this population? 
3. What are potential risk factors associated with increasing admission rates? 
The results of this investigation are presented in the manuscript, Risk of Hospital 
Admissions in Patients with Atrial Fibrillation: A Systematic Review and Meta-
analysis, which has been published in the Canadian Journal of Cardiology (see 
manuscript 1, page 35). This work was also presented at the Meeting of the European 
Society of Cardiology in 2018 as a Poster presentation. 
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2.2. Risk factors and prediction of hospital admissions 
The overall aim of this study was to identify independent predictors for all-cause 
hospital admissions in patients with established AF, and to derive and validate a 
prediction tool for this purpose.  
Objectives 
1. To identify independent risk factors associated with hospital admissions in 
patients with AF. 
2. To derive a risk prediction rule in patients with AF. 
3. To externally validate the prediction tool in another cohort of patients with AF. 
4. To build a risk score identifying patients at high risk of hospital admission. 
Specific research questions 
1. What are risk factors associated with hospital admissions in patients with AF? 
2. How can these risk factors be used to build a prediction rule for hospital 
admission? 
3. What is the predictive performance of this new prediction tool in another cohort 
of patients with diagnosed AF? 
The findings of this study are presented in the manuscript, The Admit-AF Risk Score: 
A Clinical Risk Score for Predicting Hospital Admissions in Patients with Atrial 
Fibrillation, which has been submitted to JAMA Cardiology. The findings are 
presented in manuscript 2, on page 71. 
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2.3. Psychosocial factors and hospital admission 
The overall aim of this particular study was to identify psychological and social factors 
and to assess their associations with the risk of hospital admission in patients with AF. 
Objectives 
1. To determine the prevalence of psychosocial factors and subjective health 
perception in a population of patients with AF. 
2. To assess the association of psychosocial factors and health perception with 
hospital admission in AF patients. 
3. To identify and evaluate the association between overall burden of psychosocial 
factors and admission risk in an AF population. 
Specific research questions 
1. What is the prevalence of psychosocial factors in AF patients? 
2. What is the effect of psychosocial factors on hospital admissions and which one 
are the strongest predictors for hospital admission? 
3. What is the cumulative effect of psychosocial factors and health perception on 
admission risk? 
The findings of this study are presented in the manuscript, Psychosocial Factors 
Predict Hospital Admissions in Patients with Atrial Fibrillation, which has been 
submitted to Annals of Internal Medicine. The manuscript 3 can be found on page 110. 
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3. STUDY DESIGN AND METHODS 
3.1. Objective I – Systematic review and meta-analysis 
For the first study, we performed a systematic review and meta-analysis following the 
Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) and 
the Meta-analysis of Observational Studies in Epidemiology (MOOSE) standards.58,59   
3.1.1. Eligibility criteria  
Studies were included if they fulfilled the following criteria: 
1. Cohort studies or randomized controlled trials. 
2. At least 100 patients with AF included. 
3. Reported incidence rate of all-cause hospitalization or information to calculate 
incidence rates. 
4. At least 1 year of follow-up. 
Studies were excluded if they only reported cause-specific hospitalizations, such as 
hospitalization for heart failure. 
3.1.2. Search methods  
With the assistance of an experienced research librarian, we developed a 
comprehensive search strategy and systematically searched in MEDLINE (via 
PubMed), EMBASE (via Ovid) and CENTRAL (Cochrane Central Register of 
Controlled Trials) from database inception to December 21. 2017. We used Medical 
Subject Heading (MeSH) terms and keywords such as “hospital admission,” 
“hospitalization,” and “atrial fibrillation.” No language or geographical restrictions were 
applied to the search, and abstracts were included. In addition, we screened reference 
lists of studies fulfilling inclusion criteria for additional relevant articles. Two 
independent reviewers screened titles and abstracts of all articles identified in the initial 
search. Full-texts of all potentially eligible manuscripts were reviewed by the same 
authors for eligibility. Disagreements were resolved through discussion or third party 
arbitration. In case of incomplete data, corresponding study authors were contacted 
for additional information. 
3.1.3. Data extraction and outcome assessment 
From each eligible study the following information were extracted in duplicate using a 
standardized case report form: Study design, country, year of publication, sample size, 
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AF type, follow-up duration, age of patients, sex, cardiovascular risk factors (i.e. 
hypertension, diabetes), cardiovascular comorbidities including coronary artery 
disease, heart failure, prior stroke or transient ischemic attack (TIA) and peripheral 
vascular disease; and non-cardiovascular comorbidities including chronic pulmonary 
disease, chronic kidney disease and cancer. The primary outcome of this study was 
incidence of all-cause hospital admission. We extracted the reported incidence of all-
cause hospital admissions and, if available, we also extracted incidences on 
admissions for cardiovascular versus non-cardiovascular causes. Data were entered 
into a Microsoft Access database (Microsoft Corp., Redmond, WA, USA). 
3.1.4. Study quality assessment 
We evaluated the methodological quality of included studies using a modified version 
of the Newcastle-Ottawa Scale.60 We specifically assessed the following criteria: 
Representativeness of the study population, methods used for outcome assessment, 
and adequacy of follow-up assessment. Studies were categorized as having a high (3 
points), moderate (2 points) or low study quality (≤1 point). 
3.1.5. Statistical analysis 
If not available in the original publication, we calculated the incidence of all-cause, 
cardiovascular and non-cardiovascular hospital admissions by dividing the number of 
admissions by the mean follow-up time in years multiplied with the total number of AF 
patients. We calculated 95% confidence intervals (95% CI) approximating the Poisson 
distribution. Incidence rates were pooled using random-effect models according to the 
method described by DerSimonian and Liard.61 We performed a sensitivity analysis to 
test the influence of each individual study on the overall incidence estimate by 
sequentially excluding each study and subsequently repeating meta-analysis. 
Between-study heterogeneity was computed using the Cochran’s Q statistic and 
quantified by the I2 statistic. We considered I2 values ≥50% to indicate substantial 
heterogeneity and values ≥75% considerable heterogeneity.62 
To explore between-study heterogeneity, we divided study results into subgroups 
according to predefined study-level characteristics (including geographical region, 
sample size, study design [retrospective, prospective or randomized controlled trial], 
publication status [peer-reviewed article versus abstract] and study quality) and 
compared them using random-effects meta-regression.63 Differences in incidence 
across predefined characteristics (age, sex, follow-up duration, hypertension, diabetes, 
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coronary artery disease, prior stroke or transient ischemic attack, heart failure, 
peripheral vascular disease, chronic pulmonary disease, chronic kidney disease and 
cancer) were explored using meta-regression analysis. The R2 value was used to 
indicate the proportion of between-study variability explained by the model. 
Multivariable meta-regression analyses were not performed due to the limited number 
of available studies.  
Causes for hospital admissions were extracted if available, and classified into the 
following categories: AF related, heart failure, bleeding, stroke, myocardial infarction, 
systemic embolism, bacterial and viral infections, gastrointestinal, respiratory, renal, 
neurological, cancer, endocrine and metabolic, hematological, skin and soft tissue, and 
psychiatric. Proportions of each cause category and corresponding 95% CIs were 
calculated and subsequently pooled using random-effects meta-analysis.  
Publication bias was assessed by visual inspection of funnel plots and by Egger’s 
tests.64,65 All analyses were performed using Stata, version 13.0 (StataCorp. 2013). 
Statistical tests were 2-tailed and a P<0.05 was considered to indicate statistical 
significance. 
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3.2. Objective II – Prediction tool for hospital admission 
The second study is based on data of the Swiss Atrial Fibrillation Study (Swiss-AF) 
and Basel Atrial Fibrillation Study (BEAT-AF). This work followed the Transparent 
Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis 
(TRIPOD) statement for developing and validating multivariable prediction models.66 
3.2.1. Derivation and validation cohorts  
The Swiss-AF study, an ongoing prospective, observational multicenter cohort study 
that enrolled from 2014 to 2017, 2,415 patients with established and previously 
documented AF across 14 centers in Switzerland. More methodological details have 
been published previously.43,67 Swiss-AF was used as the derivation cohort for this 
analysis. For the external validation cohort we used the BEAT-AF cohort study, an 
ongoing prospective, observational multicenter cohort study of 1,553 patients with 
previously documented AF. Patients were enrolled from 2010 to 2014 across 7 centers 
in Switzerland. In BEAT-AF, yearly information on new hospital admissions were 
collected only after the second year of follow-up. Therefore, the second year of follow-
up was used as the baseline visit in BEAT-AF. 
Inclusion criteria 
In both cohorts, similar eligibility criteria were applied.  
• AF diagnosed from a surface electrocardiogram.  
• Aged 65 years or older.  
Exclusion criteria 
• Secondary reversible forms of AF (i.e. episodes after cardiac surgery). 
• Acute illness within the last 4 weeks. 
• Inability to give informed consent. 
Patients enrolled in BEAT-AF were not eligible to participate in Swiss-AF, and vice 
versa. 
3.2.2. Study population 
From each patient, data on baseline characteristics were collected using standardized 
case report forms. These characteristics included age, sex, marital status, education, 
health perception, lifestyle factors, AF type, history of rhythm control interventions, 
history of device implantation, cardiovascular and non-cardiovascular comorbidities, 
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information on oral anticoagulation and family history of cardiovascular diseases. 
Characteristics were updated at yearly follow-up visits through on site patient visit or 
phone calls. AF type was classified according to the guidelines of the European Society 
of Cardiology into paroxysmal AF (self-terminating, usually within 48 hours), persistent 
AF (episodes either lasting longer than 7 days or requiring termination by 
electrical/pharmacologic cardioversion) or permanent AF (AF is accepted by patient 
and physician).68 
3.2.3. Outcomes 
The outcome of this study was the occurrence of unplanned all-cause hospital 
admissions after 1 year. We assessed 1-year admission risk on the basis of previous 
observational data reporting a 1-year incidence rate of hospital admission of 30%.49 
All-cause hospital admissions were defined as non-elective admissions with at least 
one overnight stay. Secondary outcomes were cardiovascular admissions (due to 
myocardial infarction, heart failure, stroke or TIA, bleeding, or deep vein thrombosis) 
and non-cardiovascular hospital admission. Information on each admission was 
obtained from patients or by review of medical files of the patients corresponding to 
the hospital admission. Planned hospital admissions for complementary investigations 
or treatment (i.e. elective pulmonary vein isolation) were excluded from this analysis. 
3.2.4. Statistical analysis 
Candidate variables were selected based on literature review, clinical plausibility and 
availability in both cohorts. Baseline characteristics of the derivation and validation 
cohorts are presented for comparison purposes. Using the derivation cohort, candidate 
variable for the prediction model were selected based on the method of least absolute 
shrinkage and selection operator (LASSO).69 LASSO is a regularized regression 
method, which penalizes the absolute size of coefficient estimates. It shrinks the β 
coefficients which allows to select the strongest variables associated with the outcome. 
As a result, variables with regression coefficients that shrink to zero are eliminated. 
The variables most strongly associated with the outcome are kept for the final model. 
Of the selected variables, time to first hospital admission was estimated by the Kaplan–
Meier method, and differences between groups were assessed by the log-rank test. A 
combined Cox proportional hazard model was used to determine the association of the 
selected variables with the cumulative incidence of hospital admissions.  
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We used a point-based risk scoring system to create a score that estimates the risk of 
hospital admissions based on the β coefficients from the model in the derivation cohort 
(rounded to the nearest integer). For each patient we calculated the total point score 
by adding together the points corresponding to risk factors. The risk score was 
categorized into three risk classes based on admission risks from the derivation, 
defined as low (<10%/year), intermediate (10-20%/year) and high risk (>20%/year). 
Discrimination of the models was evaluated using Harrell’s C statistic for survival 
models.70 Calibration was assessed graphically by comparing the observed versus the 
predicted risk at 1 and 3 years stratified by deciles.71 Kaplan-Meier curves for patients 
stratified by the 3 risk groups were generated to illustrate the risk of hospital admission 
and log-rank test was used to assess differences between groups. 
To evaluate the clinical usefulness of the prediction model, the derivation and 
validation cohorts were combined into one data set (N=3687) and the net benefit of 
using the model as a prediction tool was evaluated using decision curve analysis.72 
The net benefit is defined as the difference of the proportion of patients who are true-
positive from the proportion who are false-positive, weighted by the specific threshold 
probability. A decision curve is then created by calculating the net benefits for all 
possible thresholds. A model with a high net benefit (all positive at any threshold) is 
preferred. The curve is graphically illustrated by displaying potential thresholds for 
hospital admission risk (x axis) and the net benefit (y axis) assuming that no patient 
will have an admission.  
All analyses were performed using Stata, version 13.0 (StataCorp. 2013); variable 
selection with LASSO was performed using the lassopack.73 A 2-sided P value of <0.05 
was considered to indicate statistical significance. 
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3.3. Objective III – Psychosocial factors and hospital admission 
The third study is based on data of the Swiss-AF study. 
3.3.1. Procedures and psychosocial factors 
From each patient, we collected information on demographic and medical 
characteristics using standardized case report forms and validated questionnaires. 
Yearly follow-up visits were performed either by face-to-face contact or by telephone 
calls, to update patient characteristics, clinical measures and to collect information on 
outcome events. Follow-up visits were performed through local study personnel at 
each study center.  
Psychosocial factors consisted of marital status (married, single, divorced or widowed), 
education, and presence of depression or depressive symptoms. Information on 
marital status was ascertained at baseline. Education level was assessed using the 
sum of completed years in school, high school or college, and defined as primary or 
less (less than compulsory education curriculum, <6 years), secondary (high school or 
similar, 6-12 years) and college or university (college or university degree, >12 years). 
Depression and depressive symptoms were assessed using the Geriatric Depression 
Scale (GDS), and a total score of >5 points indicates depression.74,75 Health perception 
was self-assessed by patients indicating their current state of health using a visual 
analogue scale (VAS) ranging from 0 (worst) to 100 (best). The VAS used in this study 
is very similar to the EuroQol VAS, and has been validated for AF patients.76,77  
3.3.2. Outcomes 
The primary end point of this study was time to first all-cause hospital admission 
defined as any unplanned admission leading to at least 1 overnight stay. Secondary 
outcomes were time to first cardiovascular (due to myocardial infarction, heart failure, 
stroke/TIA, bleeding, deep vein thrombosis) and non-cardiovascular hospital 
admission. Information on the occurrence of an event was obtained from patients or 
their family doctor, who were contacted at regular yearly follow-up visits. The 
occurrence and type of the events was assessed at a yearly follow-up investigation 
(i.e., on-site visit, phone call, or information gathered from the family doctor). 
3.3.3. Statistical analysis 
Baseline characteristics are presented as mean ± standard deviation (SD) for 
continuous variables or as counts (percentages) for categorical variables. Incidence 
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rates and 95% confidence intervals (CI) for primary and secondary outcomes were 
calculated per 100 person years of follow-up. Time to first hospital admission was 
estimated and plotted using the Kaplan-Meier method. We constructed Cox 
proportional hazard models to test the associations of psychosocial factors and health 
perception with the risk of hospital admission, adjusting for cardiovascular and non-
cardiovascular covariates. These covariates included age, sex, body-mass index 
(BMI), history of hypertension, diabetes, coronary heart disease, prior stroke/TIA, heart 
failure, peripheral vascular disease, renal failure, cancer, previous falls. We 
constructed a combined multivariable model including all psychosocial factors in a 
single model to determine the strongest predictors for hospital admission. Multivariable 
and combined models included 2349 patients because of missing data in 9 patients 
(0.4 %). The appropriateness of the proportional hazards assumption was investigated 
by calculating Schoenfeld residuals.  
To evaluate overall burden of psychosocial factors and its effect on hospital admission 
risk, we used the variables that remained associated in the combined model, with a P 
value threshold of <0.05. Patients were categorized into groups according to the 
presence of the factors. We performed multivariable Cox models, adjusted for the 
same covariates as listed above, and tested for trend of the survivor function across 
groups. 
All analyses were performed using Stata, version 13 (StataCorp). All test were 2-sided 
and a p<0.05 was considered statistical significance. 
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4. MANUSCRIPT 1 – Risk of hospital admissions atrial fibrillation  
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Table S1 Sensitivity Analysis of the Incidence of All-cause Hospital 
Admissions 
Table S2 Sensitivity Analysis of the Incidence of Cardiovascular Hospital 
Admissions 
Table S3 Sensitivity Analysis of the Incidence of Non-cardiovascular 
Hospital Admissions 
Table S4 Assessment of Study Quality Using a Modified Version of the 
Newcastle Ottawa Scale (NOS) 
Figure S2 Cumulative Incidence of Cardiovascular Hospital Admissions 
Stratified by Study-Level Characteristics 
Figure S3 Cumulative Incidence of Non-cardiovascular Hospital Admissions 
Stratified by Study-Level Characteristics 
Figure S4 Meta-analysis of the Proportions of Specific Causes for 
Cardiovascular Hospital Admissions 
Figure S5 Meta-analysis of the Proportions of Specific Causes for Non-
cardiovascular Hospital Admissions 
Figure S6 Meta-regression Plots of the Associations Between Incidence of 
Hospital Admissions and Study and Patient Characteristics. 
Figure S7 Funnel Plot Assessing Small Study Effects in 35 Studies Reporting 
on the Incidence of All-cause Hospital Admissions 
Figure S8 Funnel Plot Assessing Small Study Effects in 24 Studies Reporting 
on the Incidence of  Cardiovascular Hospital Admissions 
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Figure S9 Funnel Plot Assessing Small Study Effects in 24 Studies Reporting 
on the Incidence of Non-cardiovascular Hospital Admissions 
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Figure legends 
Figure S2 Cumulative Incidence of Cardiovascular Hospital Admissions 
Stratified by Study-Level Characteristics 
Blue diamonds represent the pooled incidence estimate for each 
subgroup computed by random-effects models. Pooled estimates are 
weighted according to number of studies within the subgroups. P for 
difference between subgroups was calculated using random-effects 
meta-regression. 
Figure S3 Cumulative Incidence of Non-cardiovascular Hospital Admissions 
Stratified by Study-Level Characteristics 
Blue diamonds represent the pooled incidence estimate for each 
subgroup computed by random-effects models. Pooled estimates are 
weighted according to number of studies within the subgroups. P for 
difference between subgroups was calculated using random-effects 
meta-regression. 
Figure S4 Meta-analysis of the Proportions of Specific Causes for 
Cardiovascular Hospital Admissions 
Proportions from each study were pooled using random-effects meta-
analysis. Gray diamonds represent the pooled proportion of each specific 
cause for cardiovascular hospitalization. 
Figure S5 Meta-analysis of the Proportions of Specific Causes for Non-
cardiovascular Hospital Admissions 
Proportions from each study were pooled using random-effects meta-
analysis. Gray diamonds represent the pooled proportion of each specific 
cause for non-cardiovascular hospitalization. 
Figure S6 Meta-regression Plots of the Associations Between Incidence of 
Hospital Admissions and Study and Patient Characteristics 
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Each study is depicted by a circle, the size of the circle represents the 
weight of the study in the random-effects meta-analysis. The regression 
line is the best fit for the meta-regression model with the estimated 95% 
CI denoted as dashed lines.  
A) Association between incidence of all-cause hospital admissions and 
mean age.  
B) Association between incidence of all-cause hospital admissions and 
prevalence of chronic pulmonary disease.  
C) Association between incidence of non-cardiovascular admissions and 
mean follow-up duration.  
D) Association between incidence of non-cardiovascular admissions and 
prevalence of chronic pulmonary disease.  
E) Association between incidence of non-cardiovascular admissions and 
prevalence of cancer. 
Figure S7 Funnel Plot Assessing Small Study Effects in 35 Studies Reporting 
on the Incidence of All-cause Hospital Admissions 
Each dot represents a single study. On the x-axis are the log transformed 
incidence estimates and the corresponding standard errors are on the y-
axis. Larger studies are placed towards the top and smaller studies are 
placed towards the bottom. Visually inspected smaller studies show 
larger standard errors and larger incidence rates. Results from the 
Egger’s test indicate marginally no evidence of publication bias (p=0.06). 
Figure S8 Funnel Plot Assessing Small Study Effects in 24 Studies Reporting 
on the Incidence of Cardiovascular Hospital Admissions 
Each dot represents a single study. On the x-axis are the log transformed 
incidence estimates and the corresponding standard errors are on the y-
axis. Larger studies are placed towards the top and smaller studies are 
placed towards the bottom. Visually inspected smaller studies show 
larger standard errors and larger incidence rates. Results from the 
Egger’s test indicate statistically significant evidence of publication bias 
(p=0.05). 
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Figure S9 Funnel Plot Assessing Small Study Effects in 24 Studies Reporting 
on the Incidence of Non-cardiovascular Hospital Admissions 
Each dot represents a single study. On the x-axis are the log transformed 
incidence estimates and the corresponding standard errors are on the y-
axis. Larger studies are placed towards the top and smaller studies are 
placed towards the bottom. Visually only few studies show larger 
standard errors and larger incidence rates. Results from the Egger’s test 
indicate no statistically significant evidence of publication bias (p=0.87). 
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Figure S1 Literature Search Strategy 
 
Search documentation from 12/21/2017. 
Literature search in MEDLINE (via PubMed): 
Concept 1 
Atrial Fibrillation 
MeSH 
"Atrial Fibrillation"[Mesh] 
 
OR 
 
Keywords 
atrial fibrillation*[Title/Abstract] OR AF[Title/Abstract] OR 
AFib[Title/Abstract] OR auricular fibrillation[Title/Abstract]  
 
AND 
 
Concept 2 
Hospitalization 
MeSH 
"Hospitalization"[Mesh] OR "Patient Admission"[Mesh] OR 
"Patient Readmission"[Mesh] 
 
OR 
 
Keywords 
hospitalization*[Title/Abstract] OR 
hospitalisation*[Title/Abstract] OR hospitalized[Title/Abstract] 
OR hospitalised[Title/Abstract] OR 
rehospitalization*[Title/Abstract] OR 
rehospitalisation*[Title/Abstract] OR 
rehospitalized[Title/Abstract] OR rehospitalised[Title/Abstract] 
OR hospital admission*[Title/Abstract] OR hospital 
readmission*[Title/Abstract] 
 
Literature search in EMBASE: 
Concept 1 
Atrial Fibrillation 
Emtree 
'atrial fibrillation'/exp 
 
OR 
 
Title, abstract, keywords 
'atrial fibrillation*':ti,ab,kw OR 'AF':ti,ab,kw OR 'AFib':ti,ab,kw 
OR 'auricular fibrillation':ti,ab,kw  
 
AND 
 
Concept 2 
Hospitalization 
Emtree 
'hospitalization'/exp 
 
OR 
 
Title, abstract, keywords 
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'hospitalization*':ti,ab,kw OR 'hospitalisation*':ti,ab,kw OR 
'hospitalized':ti,ab,kw OR 'hospitalised':ti,ab,kw OR 
'rehospitalization*':ti,ab,kw OR 'rehospitalisation*':ti,ab,kw OR 
'rehospitalized':ti,ab,kw OR 'rehospitalised':ti,ab,kw OR 
'hospital admission*':ti,ab,kw OR 'hospital 
readmission*':ti,ab,kw 
 
Literature search in the CENTRAL: 
Concept 1 
Atrial Fibrillation 
MeSH 
"Atrial Fibrillation"[Mesh] 
 
OR 
 
Keywords 
atrial fibrillation*[Title/Abstract] OR AF[Title/Abstract] OR 
AFib[Title/Abstract] OR auricular fibrillation[Title/Abstract] 
 
AND 
 
Concept 2 
Hospitalization 
MeSH 
"Hospitalization"[Mesh] OR "Patient Admission"[Mesh] OR 
"Patient Readmission"[Mesh] 
 
OR 
 
Keywords 
hospitalization*[Title/Abstract] OR 
hospitalisation*[Title/Abstract] OR hospitalized[Title/Abstract] 
OR hospitalised[Title/Abstract] OR 
rehospitalization*[Title/Abstract] OR 
rehospitalisation*[Title/Abstract] OR 
rehospitalized[Title/Abstract] OR rehospitalised[Title/Abstract] 
OR hospital admission*[Title/Abstract] OR hospital 
readmission*[Title/Abstract] 
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Table S1 Sensitivity Analysis of the Incidence of All-cause Hospital Admissions 
 
  
Study excluded, Year Pooled incidence, 
per 100 person-
years 
95% confidence 
interval 
I2 
Excluding Hohnloser et al, 2000 43.6 38.3-48.9 99.9% 
Excluding Inglis et al, 2004 43.3 38.1-48.6 99.9% 
Excluding Nieuwlaat et al, 2008 42.9 37.7-48.1 99.9% 
Excluding Ahmed et al, 2009 43.1 37.9-48.4 99.9% 
Excluding Connolly et al, 2009 44.4 38.9-49.9 99.9% 
Excluding Reynolds et al, 2010 44.2 38.9-49.5 99.9% 
Excluding Yusuf et al, 2011 43.9 38.5-49.4 99.9% 
Excluding Linssen et al, 2011 42.7 37.5-48.0 99.9% 
Excluding Torp-Pedersen et al, 2011 43.2 38.0-48.4 99.9% 
Excluding Amin et al, 2012 43.0 37.7-48.2 99.9% 
Excluding Naccarelli et al, 2012 43.9 38.3-49.5 99.9% 
Excluding Piccini et al, 2012 43.7 38.4-49.0 99.9% 
Excluding Vidal-Perez et al, 2013 44.4 39.1-49.7 99.9% 
Excluding Hohnloser et al, 2013 44.3 38.9-49.6 99.9% 
Excluding Mohanty et al, 2013 44.7 39.4-49.9 99.9% 
Excluding LaPointe et al, 2014 44.3 38.4-50.3 99.9% 
Excluding Bengtson et al, 2014 42.9 37.7-48.2 99.9% 
Excluding Gallagher et al, 2014 42.3 37.4-47.2 99.9% 
Excluding Lip et al, 2014 43.8 38.5-49.1 99.9% 
Excluding Ozin et al, 2014 44.2 38.9-49.5 99.9% 
Excluding Steinberg et al, 2014 43.8 38.5-49.1 99.9% 
Excluding Whitbeck et al, 2014 43.7 38.5-48.9 99.9% 
Excluding Khazanie et al, 2014 42.6 37.6-47.6 99.9% 
Excluding Freeman et al, 2015 43.5 38.3-48.7 99.9% 
Excluding Wu et al, 2015 43.8 38.5-49.1 99.9% 
Excluding DeVore et al, 2016 44.7 39.8-49.5 99.9% 
Excluding Kuck et al, 2016 43.7 38.5-49.0 99.9% 
Excluding Steinberg et al, 2016 43.7 38.4-49.0 99.9% 
Excluding Wen et al, 2016 43.3 38.0-48.5 99.9% 
Excluding Cadrin-Tourigny et al, 2017 44.2 38.9-49.5 99.9% 
Excluding Chamberlain et al, 2017 43.2 38.1-48.4 99.9% 
Excluding Gibson et al, 2017 43.5 38.2-48.7 99.9% 
Excluding Ferguson et al, 2017 43.1 37.8-48.3 99.9% 
Excluding Vora et al, 2017 44.7 39.5-50.0 99.9% 
Excluding Zweiker et al, 2017 43.6 38.3-48.8 99.9% 
Pooled estimate 43.7 38.5-48.9 99.9% 
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Table S2 Sensitivity Analysis of the Incidence of Cardiovascular Hospital 
Admissions 
  
Study excluded, Year Pooled incidence, 
per 100 person-
years 
95% confidence 
interval 
I2 
Excluding Nieuwlaat et al, 2008 24.9 21.4-28.4 99.9% 
Excluding Reynolds et al, 2010 26.7 23.1-30.4 99.9% 
Excluding Yusuf et al, 2011 26.6 22.8-30.3 99.9% 
Excluding Linssen et al, 2011 25.4 21.7-29.0 99.9% 
Excluding Torp-Pedersen et al, 2011 25.7 22.1-29.2 99.9% 
Excluding Amin et al, 2012 25.0 21.5-28.6 99.9% 
Excluding Naccarelli et al, 2012 26.8 22.5-31.0 99.9% 
Excluding Piccini et al, 2012 26.4 22.7-30.1 99.9% 
Excluding Vidal-Perez et al, 2013 27.1 23.4-30.8 99.9% 
Excluding Hohnloser et al, 2013 26.9 23.2-30.6 99.9% 
Excluding Mohanty et al, 2013 26.3 22.7-29.9 99.9% 
Excluding LaPointe et al, 2014 27.0 22.7-31.4 99.9% 
Excluding Bengtson et al, 2014 26.6 22.9-30.2 99.9% 
Excluding Gallagher et al, 2014 26.3 22.7-29.9 99.9% 
Excluding Lip et al, 2014 26.3 22.6-29.9 99.9% 
Excluding Steinberg et al, 2014 26.5 22.8-30.2 99.9% 
Excluding Whitbeck et al, 2014 26.3 22.7-29.9 99.9% 
Excluding Khazanie et al, 2014 24.5 21.3-27.6 99.9% 
Excluding DeVore et al, 2016 27.2 23.7-30.8 99.9% 
Excluding Kuck et al, 2016 26.2 22.5-29.8 99.9% 
Excluding Steinberg et al, 2016 26.4 22.7-30.1 99.9% 
Excluding Cadrin-Tourigny et al, 2017 26.5 22.8-30.2 99.9% 
Excluding Chamberlain et al, 2017 26.6 22.9-30.2 99.9% 
Excluding Gibson et al, 2017 25.9 22.3-29.6 99.9% 
Excluding Vora et al, 2017 27.2 23.6-30.9 99.9% 
Excluding Zweiker et al, 2017 26.5 22.9-30.2 99.9% 
Pooled estimate 26.3 22.7-29.9 99.9% 
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Table S3 Sensitivity Analysis of the Incidence of Non-cardiovascular Hospital 
Admissions 
 
 
Study excluded, Year Pooled incidence, 
per 100 person-
years 
95% confidence 
interval 
I2 
Excluding Nieuwlaat et al, 2008 15.9 12.5-19.3 99.9% 
Excluding Reynolds et al, 2010 16.0 12.6-19.4 99.9% 
Excluding Yusuf et al, 2011 15.7 12.3-19.2 99.9% 
Excluding Linssen et al, 2011 15.2 12.0-18.5 99.9% 
Excluding Torp-Pedersen et al, 2011 15.6 12.3-18.9 99.9% 
Excluding Amin et al, 2012 15.9 12.6-19.2 99.9% 
Excluding Naccarelli et al, 2012 15.3 12.4-18.2 99.8% 
Excluding Piccini et al, 2012 15.6 12.3-19.9 99.9% 
Excluding Vidal-Perez et al, 2013 15.9 12.5-19.3 99.9% 
Excluding Hohnloser et al, 2013 15.9 12.5-19.2 99.9% 
Excluding Mohanty et al, 2013 15.7 12.5-18.9 99.8% 
Excluding LaPointe et al, 2014 15.7 12.0-19.3 99.8% 
Excluding Bengtson et al, 2014 14.3 11.1-17.5 99.8% 
Excluding Gallagher et al, 2014 15.7 12.5-18.9 99.8% 
Excluding Lip et al, 2014 15.9 12.6-19.1 99.9% 
Excluding Steinberg et al, 2014 15.6 12.3-19.0 99.9% 
Excluding Whitbeck et al, 2014 16.1 12.8-19.4 99.8% 
Excluding Khazanie et al, 2014 15.9 12.5-19.2 99.9% 
Excluding DeVore et al, 2016 16.1 13.2-19.1 99.8% 
Excluding Kuck et al, 2016 15.9 12.6-19.1 99.9% 
Excluding Steinberg et al, 2016 15.7 12.4-19.0 99.9% 
Excluding Cadrin-Tourigny et al, 2017 16.2 13.0-19.5 99.8% 
Excluding Chamberlain et al, 2017 14.7 11.6-17.8 99.8% 
Excluding Gibson et al, 2017 15.8 12.5-19.1 99.9% 
Excluding Vora et al, 2017 16.2 13.0-19.5 99.8% 
Excluding Zweiker et al, 2017 15.3 12.1-18.6 99.9% 
Pooled estimate 15.7 12.5-18.9 99.8% 
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Table S4 Assessment of Study Quality Using a Modified Version of the Newcastle Ottawa Scale (NOS) 
Author (study) Representativeness 
of the population 
Standardization of 
outcome assessment 
Losses to 
follow-up 
Total 
Hohnloser et al, 2000 0 
(Only persistent AF, patients 
with HF excluded) 
0 
(not reported) 
1 
(2.3%) 
1 
Inglis et al, 2004 1 
(Recurrent paroxysmal or 
sustained AF patients) 
1 
(Computerized medical records 
system and individual case 
records.) 
1 
(Minimal loss, but no 
description) 
3 
Nieuwlaat et al, 2008 1 
(18 years or older and had AF 
on ECG or Holter recording) 
1 
(medical records and patient 
interview) 
0 
(20%) 
2 
Ahmed et al, 2009 1 
(Patients with history of AF) 
1 
(Investigators were blinded to 
the outcome ascertained) 
0 
(not reported) 
2 
Connolly et al, 2009 1 
(AF documented on ECG) 
1 
(Two blinded independent 
investigators performed 
outcome assessment) 
1 
(0.1%) 
3 
Reynolds et al, 2010 1 
(AF/AFL documented on ECG) 
1 
(Standardized case report 
forms) 
0 
(not reported) 
2 
Yusuf et al, 2011 1 
(Permanent AF or at least two 
episodes of intermittent AF in 
the previous 6 months) 
1 
(Independent blind 
assessment) 
1 
(2.5%) 
3 
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Linssen et al, 2011 1 
(Heart failure population with 
and without diagnosed AF on 
ECG) 
1 
(chart reviews, databases and 
interviews) 
0 
(not reported) 
2 
Torp-Pedersen et al, 2011 1 
(Patients with paroxysmal or  
persistent AF, or AFL) 
1 
(Categorized by the 
 investigator) 
1 
(0.04%) 
3 
Amin et al, 2012 1 
(Patients hospitalized with 
AF/AFL as the primary 
diagnosis [ICD]) 
1 
(Recordings for outcome 
assessment: PharMetrics 
Patient-Centric database) 
0 
(not reported) 
2 
Naccarelli et al, 2012 0 
(AF patients aged <65 years 
and with histories of heart 
failure were excluded) 
1 
(Classified using the primary 
ICD-9-CM diagnosis code) 
0 
(not reported) 
1 
Piccini et al, 2012 1 
(AF patients aged <65 years 
were excluded) 
1 
(Categorized hospitalizations 
using ICD-9-CM codes) 
0 
(not reported) 
2 
Vidal-Perez et al, 2013 1 
(GP enrolled all his/her patients 
aged >18 years with AF) 
1 
(Assessment from patients' 
clinical interview and hospital 
records) 
1 
(2.5%) 
3 
Hohnloser et al, 2013 1 
(Patients aged ≥50 years and 
ECG documented AF) 
1 
(From local investigator through 
hospitalization case report 
forms) 
1 
(not reported) 
2 
Mohanty et al, 2013 0 
(Only patients with paroxysmal 
AF and right-AFL) 
0 
(not reported) 
0 
(not reported) 
0 
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LaPointe et al, 2014 1 
(AF patients aged <65 years) 
1 
(ICD-9-CM codes were used for 
assessment) 
0 
(not reported) 
2 
Bengtson et al, 2014 1 
(AF patients aged >65 years) 
1 
(Medicare claims were 
classified based on the primary 
discharge diagnosis code [ICD-
9-CM codes]) 
0 
(not reported) 
2 
Gallagher et al, 2014 1 
(AF documented in data bases) 
1 
(From databases using primary 
 ICD-10 codes) 
0 
(not reported) 
2 
Lip et al, 2014 1 
(ECG-confirmed diagnosis of 
AF) 
1 
(by local cardiologist 
investigator) 
0 
(15%) 
2 
Ozin et al, 2014 1 
(Patients aged >18 years with 
AF) 
0 
(not reported) 
0 
(not reported) 
1 
Steinberg et al, 2014 1 
(Patients aged >18 years and 
had ECG-confirmed diagnosis 
of AF.) 
1 
(Web-based case report form 
using patients' medical record 
and information from 
physicians) 
1 
(0%) 
3 
Whitbeck et al, 2014 1 
(AF patients aged ≥65 years 
and a least one comorbidity) 
1 
(Investigators were blinded to 
the outcome ascertained) 
0 
(not reported) 
2 
Khazanie et al, 2014 1 
(Patients aged ≥65 years with 
AF diagnosis based on the ICD-
9-CM code) 
1 
(Identified on the basis of 
inpatient claims) 
0 
(not reported) 
2 
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Freeman et al, 2015 1 
(Patients aged ≥21 years and 
diagnosed AF or AFL based on 
the ICD-9-CM code) 
1 
(Using comprehensive hospital 
discharge and billing claims 
databases) 
1 
(0%) 
3 
Wu et al, 2015 1 
(Albertans aged ≥20 years with 
diagnosed AF in any healthcare 
encounter using the ICD-9-CM 
code) 
0 
(not reported) 
0 
(not reported) 
1 
DeVore et al, 2016 1 
(Patients with paroxysmal or 
persistent AF.) 
1 
(Standardized questionnaire 
was used to query patients for 
all-cause hospitalizations) 
1 
(0.23%) 
3 
Kuck et al, 2016 0 
(Only patients with paroxysmal 
AF) 
1 
(Personal study visits and 
phone interviews) 
1 
(1%) 
2 
Steinberg et al, 2016 1 
(Patients ≥21 years of age with 
ECG-confirmed diagnosis of 
AF) 
1 
(Web-based case report form 
was used) 
0 
(not reported) 
2 
Wen et al, 2016 0 
(All patients had history of 
ischemic stroke) 
1 
(Outpatient and inpatient 
medical records were followed) 
0 
(not reported) 
1 
Cadrin-Tourigny et al, 2017 0 
(All AF patients had 
concomitant heart failure) 
1 
(Outcomes were reviewed and 
classified by an independent 
blinded adjudicating committee) 
1 
(9.7%) 
2 
Chamberlain et al, 2017 1 
(Patients ≥18 years of age and 
AF diagnosis using the ICD-9-
CM code) 
1 
(Data were obtained from a 
medical records-linkage system 
[REP]) 
0 
(not reported) 
2 
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Ferguson et al, 2017 1 
(Patients aged ≥18 years and 
with heart failure and 
concomitant AF of any type) 
1 
(Data were obtained using a 
standardized case report form) 
0 
(not reported) 
2 
Gibson et al, 2017 1 
(Patients >18 years of age with 
ECG-confirmed diagnosis of 
paroxysmal, persistent, or 
permanent AF) 
1 
(Two physicians blinded to 
study drug assignment were 
classified with a list of adverse 
events associated with 
rehospitalization) 
1 
(0%) 
3 
Vora et al, 2017 1 
(All AF types considered) 
1 
(Inperson visit at the 
recruitment site) 
0 
(10.55%) 
2 
Zweiker et al, 2017 0 
(Only patients undergoing 
TAVI) 
1 
(Inpatient records and physical 
archives were reviewed) 
0 
(not reported) 
1 
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Figure S2 Cumulative Incidence of Cardiovascular Hospital Admissions Stratified 
by Study-Level Characteristics 
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Figure S3 Cumulative Incidence of Non-cardiovascular Hospital Admissions 
Stratified by Study-Level Characteristics 
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Figure S4 Meta-analysis of the Proportions of Specific Causes for Cardiovascular Hospital Admissions 
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Figure S5 Meta-analysis of the Proportions of Specific Causes for Non-cardiovascular Hospital Admissions 
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Figure S6 Meta-regression Plots of the Associations Between Incidence of 
Hospital Admissions and Study and Patient Characteristics 
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Figure S7 Funnel Plot Assessing Small Study Effects in 35 Studies Reporting on the Incidence of All-cause Hospital Admissions 
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Figure S8 Funnel Plot Assessing Small Study Effects in 24 Studies Reporting on the Incidence of Cardiovascular Hospital 
Admissions 
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Figure S9 Funnel Plot Assessing Small Study Effects in 24 Studies Reporting on the Incidence of Non-cardiovascular Hospital 
Admissions 
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5. MANUSCRIPT 2 – Risk score predicting hospital admission in 
atrial fibrillation 
 
The Admit-AF Risk Score: A Clinical Risk Score for Predicting Hospital 
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Key Points 
Question: Can a risk score accurately predict future hospital admissions in unselected 
patients with atrial fibrillation (AF)? 
Findings: A risk score was developed in 2387 patients, and externally validated in 
1300 patients. Variables selected for the score were age, prior pulmonary vein 
isolation, hypertension, diabetes, coronary heart disease, prior stroke/TIA, heart 
failure, peripheral artery disease, cancer, renal failure, and previous falls. The score 
was well calibrated, and successfully validated in an independent cohort.  
Meaning: Multiple risk factors were associated with hospital admissions in AF patients. 
Our prediction tool selects high-risk patients who may benefit from preventive 
interventions. 
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Abstract 
Importance: Patients with atrial fibrillation (AF) have a high risk of hospital admissions, 
but there is no validated prediction tool to identify those at highest risk.   
Objective: To develop and externally validate a risk score for all-cause hospital 
admissions in patients with AF. 
Design, Setting, and Participants: Derivation cohort of 2387 patients with 
established AF in Switzerland; Validation cohort in a separate prospective, multicenter 
cohort of 1300 AF patients. Data were analyzed from March 26 to August 23, 2019.  
Exposures: Independent risk factors were selected from a broad range of variables 
using the least absolute shrinkage and selection operator (LASSO) method fit to a Cox 
regression model.  
Main Outcomes and Measures: Time to first unplanned hospital admission.  
Results: In the derivation cohort (mean age: 73 years, 27% women), 891 patients 
(37.3%) were admitted to the hospital during a median follow-up of 2.0 years. In the 
validation cohort (mean age: 70 years, 30% women), hospital admission occurred in 
719 patients (55.3%) during a median follow-up of 1.9 years. The most important 
predictors for admission were age (75-79 years: adjusted hazard ratio [aHR], 1.33; 
95% confidence interval [95% CI], 1.00-1.77; 80-84 years: aHR, 1.51; 95% CI, 1.12-
2.03; ≥85 years: aHR, 1.88; 95% CI, 1.35-2.61), prior pulmonary vein isolation (aHR, 
0.74; 95% CI, 0.60-0.90), hypertension (aHR, 1.16; 95% CI, 0.99-1.36), diabetes (aHR, 
1.38; 95% CI, 1.17-1.62), coronary heart disease (aHR, 1.18; 95% CI, 1.02-1.37), prior 
stroke/TIA (aHR, 1.28; 95% CI, 1.10-1.50), heart failure (aHR, 1.21; 95% CI, 1.04-
1.41), peripheral artery disease (aHR, 1.31; 95% CI, 1.06-1.63), cancer (aHR, 1.33; 
95% CI, 1.13-1.57), renal failure (aHR, 1.18, 95% CI, 1.01-1.38), and previous falls 
(aHR, 1.44; 95% CI, 1.16-1.78). A risk score with these variables was well calibrated, 
and achieved a C-index of 0.64 (95% CI, 0.61-0.66) in the derivation and 0.59 (95% 
CI, 0.56-0.63) in the validation cohort.  
Conclusions and Relevance: Multiple risk factors were associated with hospital 
admissions in AF patients. Our prediction tool selects high-risk patients who may 
benefit from preventive interventions.  
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Introduction 
Atrial fibrillation (AF) is increasing in prevalence and an important risk factor for hospital 
admissions.1,2 The overall risk of being admitted to the hospital among patients with 
AF is approximately 44% per year, which is 1.6 times higher than non-AF 
populations.3,4  
It is well-established that AF patients have a high prevalence of cardiovascular risk 
factors and comorbidities,5 which is one reason why they face an increased risk of 
cardiovascular and non-cardiovascular adverse events.6-9 However, it is currently 
unclear which of the many potential comorbidities independently contribute to the high 
risk of hospital admissions and whether at least some of them are preventable. 
A recent systematic review suggested that 50 to 70% of the total annual costs in AF 
are directly attributable to hospital admissions, making it the highest proportion of direct 
healthcare spending in this population.10 But this is an important issue not only from a 
monetary perspective, because AF patients with a previous hospital admission have a 
significantly higher risk of adverse outcome events and death after discharge.11 
Therefore, we need major efforts to prevent hospital admissions in this growing patient 
population. An accurate and practical risk predication tool may help to identify high risk 
AF patients who may then be targeted with specific interventions.12 
In this context, the objective of this study was to identify factors associated with hospital 
admissions in a large group of AF patients, and to derive and validate a risk prediction 
tool in this patient population. 
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Methods 
This study followed the Transparent Reporting of a Multivariable Prediction Model for 
Individual Prognosis or Diagnosis (TRIPOD) statement for developing and validating 
multivariable prediction models.13 
Cohorts 
Between 2014 and 2017, the Swiss Atrial Fibrillation (Swiss-AF) observational 
multicenter cohort study enrolled 2,415 patients with previously documented AF across 
14 centers in Switzerland. Methodological details have been published previously.14,15 
Swiss-AF was used as the derivation cohort for this analysis.  
For external validation, we used data from the Basel Atrial Fibrillation (BEAT-AF) 
cohort, an ongoing prospective, observational multicenter cohort study of 1,553 
patients with previously documented AF. Patients were enrolled from 2010 to 2014 
across 7 centers in Switzerland. In BEAT-AF, we started collecting yearly information 
on hospital admissions the second year of follow-up. For the purpose of this analysis 
we therefore used the second year visit as baseline in BEAT-AF.  
In both cohorts, eligible patients had AF previously diagnosed by surface 
electrocardiogram. Patients were excluded if they had secondary forms of AF or were 
unable to sign informed consent. Patients enrolled in BEAT-AF could not participate in 
Swiss-AF. Both study protocols were approved by the local ethics committees, and 
written informed consent was obtained from all participants. 
Study Population 
Data on a large number of baseline characteristics and comorbidities were collected 
using standardized case report forms that were very similar between the two cohorts. 
These characteristics included age, sex, marital status, education, health perception, 
lifestyle habits, AF type, history of rhythm control interventions, history of device 
implantation, cardiovascular and non-cardiovascular comorbidities, information on oral 
anticoagulation and family history of cardiovascular diseases. AF type was classified 
according to the guidelines of the European Society of Cardiology into paroxysmal AF 
(self-terminating, usually within 48 hours), persistent AF (episodes either lasting longer 
than 7 days or requiring termination by electrical/pharmacologic cardioversion) or 
permanent AF (AF is accepted by patient and physician).16 
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Study Outcome Assessment 
The main outcome for this analysis was any unplanned overnight hospital admission. 
In both cohorts, information on admissions was obtained from patients and by medical 
record review during yearly follow-up visits. In this analysis we only looked at time to 
first hospital admission. Elective hospital admissions were not considered an event.  
Statistical Analysis  
Candidate variables for our analyses were selected based on literature review, clinical 
plausibility and availability in both cohorts, with the aim of being inclusive given the 
large number of endpoints available. Using the derivation cohort, independent 
predictors for the model were selected based on the least absolute shrinkage and 
selection operator (LASSO) method.17 LASSO is a linear regression analysis that 
simultaneously performs variable selection and regularization using machine learning 
algorithms. The method takes all candidate variables into one model, and shrinks the 
absolute size of the regression coefficients towards zero. This shrinkage is achieved 
by placing a penalty to the summation of estimated regression coefficients. As a result, 
variables with regression coefficients that shrink to zero are eliminated. The variables 
most strongly associated with the outcome are kept in the model. These independent 
variables were entered in a multivariable-adjusted Cox proportional hazards model to 
assess their associations with time to first hospital admission. 
We established a point-based risk scoring system for unplanned hospital admissions, 
based on the regression coefficients from the derivation cohort model (rounded to the 
nearest integer).18 We calculated the total point score for each patient. The risk score 
was categorized into three risk classes based on admission risks from the derivation, 
defined as low (<10%/year), intermediate (10-20%/year) and high risk (>20%/year). 
Kaplan-Meier curves were used to compare the incidence of hospital admissions 
across risk score categories. Its predictive ability was validated in the external 
validation cohort. Model discrimination was assessed using Harrell’s C statistic for 
survival models.19 Calibration was assessed graphically by comparing the observed 
versus the predicted risk at 1 and 3 years stratified by deciles.20  
In order to evaluate the clinical usefulness of the prediction model, the derivation and 
validation cohorts were combined into one data set (N=3687) and the net benefit of 
using the model as a prediction tool was evaluated using decision curve analysis.21 
The net benefit is defined as the difference of the proportion of patients who are true-
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positive from the proportion who are false-positive, weighted by the specific threshold 
probability. A decision curve is then created by calculating the net benefits for all 
possible thresholds. A model with a high net benefit (all positive at any threshold) is 
preferred. The curve is graphically illustrated by displaying potential thresholds for 
hospital admission risk (x axis) and the net benefit (y axis) assuming that no patient 
will have an admission.  
All analyses were performed using Stata, version 13 (StataCorp. 2013. College 
Station, TX: StataCorp LP.); variable selection with LASSO was performed using the 
lassopack.22 A 2-sided P value of <0.05 was considered to indicate statistical 
significance. 
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Results 
A total of 2,387 AF patients were included in the derivation cohort and 1,300 patients 
in the external validation cohort (Figure S1 in the Supplement). Baseline characteristics 
stratified by cohort are presented in Table 1. The mean (±SD) age was 73 (8) years in 
the derivation cohort and 70 (12) years in the validation cohort; 27% and 30% were 
women, respectively. Over 90% of patients in the derivation cohort and 67% in the 
validation cohort were on oral anticoagulation.  
In the derivation cohort, 891 patients (37.3%) were admitted to the hospital after a 
median follow-up of 2.0 years (4664 person-years of follow-up), with an incidence rate 
of 19.1 (95% confidence interval [CI], 17.9-20.4) per 100 person-years. Cardiovascular 
admissions occurred in 377 (15.8%) and non-cardiovascular in 629 (26.4%) (Table S1 
in the Supplement). From the 41 initially tested variables (Table S2 in the Supplement), 
LASSO identified 11 variables independently associated with the risk of hospital 
admission: age, previous pulmonary vein isolation (PVI), hypertension, diabetes, 
coronary heart disease, prior stroke or transient ischemic attack (TIA), heart failure, 
peripheral vascular disease, cancer, renal failure and previous falls (Figures S2 and 
S3 in the Supplement). Table 2 lists the adjusted regression coefficients and hazard 
ratios from the derivation cohort of the 11 variables. The hospital admission risk was 
higher in older patients (75-79 year: adjusted hazard ratio [aHR], 1.33; 95% confidence 
interval [95% CI], 1.00-1.77; 80-84 years: aHR, 1.51; 95% CI, 1.12-2.03; 85 years: 
aHR, 1.88; 95% CI, 1.35-2.61), and in those with diabetes (aHR, 1.38; 95% CI, 1.17-
1.62), coronary heart disease (aHR, 1.18; 95% CI, 1.02-1.37), prior stroke/TIA (aHR, 
1.28; 95% CI, 1.10-1.50), heart failure (aHR, 1.21; 95% CI, 1.04-1.41), peripheral artery 
disease (aHR, 1.31; 95% CI, 1.06-1.63), renal failure (aHR, 1.18, 95% CI, 1.01-1.38), 
cancer (aHR, 1.33; 95% CI, 1.13-1.57) and previous falls (aHR, 1.44; 95% CI, 1.16-
1.78). Previous PVI was inversely associated with the risk of hospital admission (aHR, 
0.74; 95% CI, 0.60-0.90).  
The multivariable adjusted regression coefficients from the derivation cohort were used 
to construct the Hospital Admission in Atrial Fibrillation (Admit-AF) risk score for 
hospital admissions (Figure 2). The number of points assigned to each risk factor is 
presented in Table S3 in the Supplement. The Admit-AF score achieved a c-index of 
0.64 (95% CI, 0.61-0.66) for 1-year predicted risk and 0.63 (95% CI, 0.61-0.65) for 3-
year hospital admission risk (Figures S4A and S4C in the Supplement). The cumulative 
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incidence of hospital admission up to 4 years in the derivation cohort is shown in Figure 
1A. Hazard ratios for 1-year risk across predefined risk classes were 2.2 for 
intermediate versus low risk, and 4.1 for high versus low risk for Admit-AF score (Table 
3). Hazard ratios for the 3-year admission risk were similar (Table 3).  
In the validation cohort, the incidence rate for incident hospital admissions was 26.1 
(95% CI, 24.2-28.1) per 100 person-years. Cardiovascular and non-cardiovascular 
admissions occurred in 357 (27.5%) and 514 (39.5%), respectively (incidence rates, 
see Table S1 in the Supplement). The risk score yielded a c-index of 0.59 (95% CI, 
0.56-0.63) for the 1-year risk and 0.59 (95% CI, 0.57-0.61) for 3-year hospital 
admission risk (Figures S5B and S5D in the Supplement).  
The models were well calibrated for 1-year and 3-year risk prediction in both the 
derivation and the validation cohort (Figures S4A-S4D in the Supplement). The 
probability of hospital admission up to 4 years in the validation cohort is presented in 
Figure 2B. Hazard ratios for 1-year risk were 1.3 for intermediate versus low risk, and 
1.7 for high versus low risk. Hazard ratios for 3-year risk of hospital admission were 
1.4 and 2.0, respectively (Table 3). Decision curve analysis indicated a consistent 
positive net benefit of using the risk score for decision of 1-year and 3-year hospital 
admission risk, as shown in Figure S5 in the Supplement. 
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Discussion 
This comprehensive analysis investigated risk factors for hospital admissions in 
patients with AF. Several important findings were identified. First, the cumulative 
incidence of hospital admission was very high in both the derivation and the validation 
cohort. Second, many independent risk factors predicted hospital admissions. Third, 
the Admit-AF score for 1-year and 3-year risk prediction was established and validated. 
The use of this score provided a significant net clinical benefit in decision curve 
analysis.  
The Admit-AF score is easy to calculate, consisting of variables that are readily 
available during regular patient visits. Calculation of the score is straightforward and it 
can be widely implemented. In contrast to other hospital admission scores, using 
retrospective administrative data and short-term follow-up,23 our score uses 
prospective real time data predicting longer-term admission risks. The score was built 
using appropriate statistical methods, and the model development process adhered to 
the TRIPOD statement.13 The use of machine learning algorithms from LASSO for 
variable selection is a well-established method that has been previously utilized in non-
AF populations.24-26 The advantage of this method is that is produces a stable model, 
which is particularly important when it is applied to other external cohorts. Indeed, our 
model was robust and well calibrated in both the derivation and in the validation 
cohorts.  
A recent meta-analysis demonstrated that the average admission rate in AF patients 
across several studies was 44% per year.3 While most of these admissions were due 
to cardiovascular causes, over one-third were attributable to non-cardiovascular 
causes. The current study confirmed the high admission rate, but demonstrated that 
admissions for non-cardiovascular causes were more common than those for 
cardiovascular reasons. This can be explained by two factors. First, in contrast to 
randomized trials, AF patients in cohort studies may have more medical comorbidities 
and exhibit a lower health status, which may result in higher admission rates for non-
cardiovascular causes. Second, prior studies mainly focused on specific types of 
admissions, such as cardiovascular or short-term readmissions after hospital 
discharge. Our study was more inclusive with evaluating any unplanned hospital 
admissions.  
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Hospital admission is a highly heterogeneous outcome without a single underlying 
cause. Many clinical variables therefore impact only a part of the overall endpoint. The 
Admit-AF risk score consists of variables from both the cardiovascular (i.e. 
hypertension, diabetes, heart failure) and non-cardiovascular domain (i.e. cancer, 
renal failure, previous falls). Large observational studies found similar associations of 
these variables with hospital admissions in AF patients.11,27 In addition, we found that 
cancer and previous falls were both strongly related to admission risk. This is an 
important finding as several studies have shown an association of AF with both cancer 
and recurrent falls.9,28 Given this heterogeneity, it seems likely that only a 
multidisciplinary integrated approach will help to improve patient outcomes by reducing 
hospital admissions in AF patients. 
Prediction tools such as the Admit-AF score can be used to identify patients at high 
risk for hospital admissions who may benefit most from preventive interventions. A 
recent work demonstrated that a multidisciplinary AF treatment pathway resulted in a 
3.7-fold reduction in hospital admissions and a 1.6-fold reduction in average length-of-
stay for admitted AF patients.29 The Hospital Readmissions Reduction Program 
(HRRP) has recently been proposed as possible intervention to reduce costly 
readmissions.30 This program reduces payments to hospitals with excess readmission, 
and it successfully reduced short- and long-term admissions in patients with heart 
failure, but there seems to be a tradeoff with an increase in 30-day and 1-year 
mortality.31 Nonetheless, these interventions are mainly hospital-based and it is 
unclear whether they are applicable in outpatient setting. Primary care and home-
based interventions need to be developed, to reduce the likelihood of hospital 
admission in AF patients. Such interventions have shown favorable results in heart 
failure patients.32  
Strengths and Limitations 
Deriving our model in a large multicenter population-based cohort of well-characterized 
patients with a very low rate of missing values and being able to validate the model 
using a similar, high quality, external source lends much strength to our results. 
Nevertheless, this study has some potential limitations that need to be acknowledged. 
The model predicts only time to first hospital admissions, ignoring repetitive admissions 
which usually occurs more often in high-risk patients. Also, the score does not include 
elective admissions, which suggests that the overall admission problem may even be 
underestimated. Finally, both the derivation and the validation cohort have been 
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established in Switzerland, and the generalizability of the model to other populations 
or health care systems remains to be determined.  
In conclusion, we identified a multitude of risk factors for hospital admissions in patients 
with established AF, suggesting that a multi-factorial approach is essential to reduce 
the admission rate in this high risk patient population. The Admit-AF score contains 11 
readily available variables, and will help to identify high-risk AF patients who may 
benefit from preventive strategies. 
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Abbreviations 
AF   Atrial fibrillation 
CHD   Coronary heart disease 
LASSO  Least absolute shrinkage and selection operator 
PAD   Peripheral artery disease 
PVI   Pulmonary vein isolation 
SD   Standard deviation 
TIA   Transient ischemic attack 
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Figure legends 
Figure 1 Kaplan–Meier Curves for Incident Hospital Admissions According 
to Risk Score Categories 
The risk classes were categorized based on admission risks from the derivation, 
defined as low (<10%/year), intermediate (10-20%/year) and high risk (>20%/year). 
Figure 2 Admit-AF Score for Hospital Admissions in AF Patients 
Abbreviations: PVI, pulmonary vein isolation; CHD, coronary heart disease, TIA, 
transient ischemic attack; PAD, peripheral artery disease. 
Data are presented for all patients (N=3687) and predicted hospital admission risk was 
estimated over the entire follow-up duration. Points can be assigned for each variable 
and summed to obtain a total risk score, which can be used to determine the patient’s 
corresponding predicted risk of hospital admission. 
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Table 1 Baseline Characteristics of the Derivation and External Validation 
Cohort 
Characteristics 
Swiss-AF 
Derivation Cohort 
(N=2387) 
BEAT-AF 
Validation Cohort 
(N=1300) 
Demographics   
 Age, mean (SD), y 73.2 (8.4) 69.8 (11.5) 
 Female sex, n (%) 652 (27.3) 386 (29.7) 
Smoking status, n (%)   
 Current 174 (7.3) 90 (6.9) 
 Past 1162 (48.7) 604 (46.5) 
 Never 1049 (44.0) 605 (46.6) 
Atrial fibrillation type, n (%)   
 Paroxysmal 1070 (44.8) 777 (59.9) 
 Persistent 702 (29.4) 251 (19.3) 
 Permanent 615 (25.8) 270 (20.8) 
Coexistent atrial flutter, n (%) 508 (21.3) 327 (25.2) 
Comorbidities, n (%)   
 Hypertension 1658 (69.5) 876 (67.4) 
 Diabetes 406 (17.0) 173 (13.3) 
 Coronary artery disease 727 (30.5) 287 (22.1) 
 Stroke/TIA 475 (19.9) 183 (14.1) 
 Heart failure 617 (25.9) 263 (20.3) 
 Peripheral artery disease 192 (8.0) 82 (6.3) 
 Obstructive sleep apnea 358 (15.0) 149 (11.5) 
 Pulmonary embolism/DVT 216 (9.1) 101 (7.8) 
 Renal failure 500 (21.0) 205 (15.8) 
 Cancer 380 (15.9) 238 (18.3) 
 Bleeding 371 (15.5) 163 (12.5) 
 Peptic ulcer 106 (4.4) 71 (5.5) 
 Recurrent falls 200 (8.4) 100 (7.7) 
CHA2DS2-VASc score, mean (SD) 3.5 (1.7) 2.9 (1.7) 
Oral anticoagulation, n (%) 2157 (90.4) 890 (68.5) 
 Warfarin 940 (39.4) 670 (51.5) 
 Direct oral anticoagulants 1216 (51.0) 220 (16.9) 
Antiplatelet therapy, n (%) 471 (19.7) 240 (18.5) 
Family history, n (%)   
 Hypertension 859 (36.0) 618 (47.5) 
 Diabetes 528 (22.1) 299 (23.0) 
 Obesity 772 (32.3) 422 (32.5) 
 Coronary heart disease 921 (38.6) 518 (39.9) 
Abbreviations: DVT, deep vein thrombosis. 
Bleeding was defined as major or minor bleeding. 
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Table 2 Adjusted Predictors for Incident Hospital Admission in the 
Derivation Cohort 
 Model  
Predictors β Coefficient (SE) Adjusted HR (95% CI) P Value 
Age, year    
 <65 1 [Reference] NA NA 
 65-69 0.12 (0.15) 1.13 (0.84-1.51) 0.42 
 70-74 0.14 (0.14) 1.15 (0.87-1.53) 0.32 
 75-79 0.29 (0.15) 1.33 (1.00-1.77) 0.049 
 80-84 0.41 (0.15) 1.51 (1.12-2.03) 0.007 
 ≥85 0.63 (0.17) 1.88 (1.35-2.61) <0.001 
Previous PVI -0.31 (0.10) 0.74 (0.60-0.90) 0.003 
Hypertension 0.15 (0.08) 1.16 (0.99-1.36) 0.06 
Diabetes 0.32 (0.08) 1.38 (1.17-1.62) <0.001 
Coronary artery disease 0.17 (0.07) 1.18 (1.02-1.37) 0.023 
Prior stroke/TIA 0.25 (0.08) 1.28 (1.10-1.50) 0.002 
Heart failure 0.20 (0.08) 1.21 (1.04-1.41) 0.012 
Peripheral artery disease 0.27 (0.11) 1.31 (1.06-1.63) 0.014 
Renal failure 0.16 (0.08) 1.18 (1.01-1.38) 0.043 
Cancer 0.29 (0.08) 1.33 (1.13-1.57) 0.001 
Previous falls 0.36 (0.11) 1.44 (1.16-1.78) 0.001 
Abbreviations: SE, standard error; HR, hazard ratio; NA, not applicable. 
The model includes all variables listed (age, previous PVI, hypertension, diabetes, 
coronary heart disease, prior stroke/TIA, heart failure, peripheral artery disease, renal 
failure, cancer, previous falls). 
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Table 3 Risk of Hospital Admission According to Risk Score Categories 
  1-Year Risk   3-Year Risk  
Risk Category 
No. of 
Patients (%) Events Incidence* HR (95% CI) 
 
Events Incidence* HR (95% CI) 
Derivation Cohort (N=2387)         
 Low risk (-3-1 points) 400 (16.8) 33 8.58 (6.10-12.07) 1 [Reference]  71 8.05 (6.38-10.16) 1 [Reference] 
 Intermediate risk (2-7 points) 974 (40.8) 165 18.71 (16.07-21.80) 2.18 (1.50-3.17)  294 15.83 (14.12-17.75) 1.94 (1.50-2.52) 
 High risk (≥8 points) 1013 (42.4) 299 34.94 (31.20-39.14) 4.07 (2.84-5.84)  485 29.81 (27.27-32.59) 3.59 (2.80-4.61) 
Validation Cohort (N=1300)         
 Low risk (-3-1 points) 386 (29.7) 72 20.55 (16.31-25.89) 1 [Reference]  159 19.14 (16.38-22.36) 1 [Reference] 
 Intermediate risk (2-7 points) 479 (36.9) 110 25.84 (21.44-31.15) 1.26 (0.94-1.70)  244 27.04 (23.85-30.66) 1.42 (1.16-1.74) 
 High risk (≥8 points) 435 (33.5) 124 33.75 (28.30-40.24) 1.66 (1.24-2.21)  254 36.71 (32.46-41.51) 1.95 (1.60-2.38) 
Abbreviations: HR, hazard ratio. 
* per 100 person-years of follow-up. 
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Figure 1 Kaplan–Meier Curves for Incident Hospital Admissions According to Risk Score Categories 
A Derivation Cohort 
 
B Validation Cohort 
 
  
High risk 
(≥8 points) Log rank 
Intermediate 
risk (2-7 points) 
Low risk 
(-3-1 points) 
High risk 
(≥8 points) 
Intermediate risk 
(2-7 points) 
Low risk 
(-3-1 points) 
Log rank 
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Figure 2 Admit-AF Score for Hospital Admissions in AF Patients 
 
 
 
 
 
 
 
Age, y Points 
<65 0 
65-69 1 
70-74 1 
75-79 3 
80-84 4 
≥85 6 
 
Previous PVI Points 
No 0 
Yes 3 
 
History of hypertension Points 
No 0 
Yes 2 
 
History of diabetes Points 
No 0 
Yes 3 
 
History of CHD Points 
No 0 
Yes 2 
 
Prior stroke/TIA Points 
No 0 
Yes 3 
History of heart failure Points 
No 0 
Yes 2 
History of PAD Points 
No 0 
Yes 3 
 
History of cancer Points 
No 0 
Yes 3 
 
History of renal failure Points 
No 0 
Yes 2 
 
Previous falls Points 
No 0 
Yes 4 
 
Sum of points  
Age + 
Previous PVI - 
History of hypertension + 
History of diabetes + 
History of CHD + 
Prior stroke/TIA + 
History of heart failure + 
History of PAD + 
History of cancer + 
History of renal failure + 
Previous falls + 
Total Risk Score=  
 
  Patients in Risk Quintile, No. (%) 
Risk Score 
Quintile 
Predicted Risk of 
Hospital Admission, % 
Derivation 
Cohort 
Validation 
Cohort 
-3-2 12-18 485 (20) 462 (36) 
3-5 >18-20 549 (23) 272 (21) 
6-8 >20-25 558 (23) 214 (16) 
9-11 >25-37 367 (15) 172 (13) 
≥12 >37 428 (18) 180 (14) 
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Table S1. Incidence of All-cause, Cardiovascular and Non-cardiovascular Hospital Admissions in the Derivation and 
Validation Cohort 
 Cohort     
 Swiss-AF Derivation Cohort  BEAT-AF Validation Cohort 
Outcome Events/No. at risk Incidence*  Events/No. at risk Incidence* 
All-cause hospital admission 891/2387 19.1 (17.9-20.4)  719/1300 26.1 (24.2-28.1) 
Cardiovascular hospital admission 377/2387 7.0 (6.3-7.7)  357/1300 10.3 (9.3-11.4) 
Non-cardiovascular hospital admission 629/2387 12.4 (11.5-13.4)  514/1300 16.2 (14.9-17.7) 
* per 100 person-years of follow-up. 
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Table S2. Variables included in the LASSO Variable Selection Method 
Variable Data Source Comment 
Age CRF Age in years 
Sex CRF Female, male 
Marital status CRF Married, single, divorced, 
widowed 
Education level CRF Basic (<6 years), middle 
(6-12 years), advanced 
(>12 years) 
Visual analogue scale CRF 0-100 
Smoking status CRF Never, past, active 
Alcohol consumption CRF Non, <1 drink/day, 1-2 
drinks/day, >2 drinks/day 
Caffeine intake CRF Non, <1 cup/day, 1-2 
cup/day, >2 cup/day 
Physical activity CRF Rarely/never, 1-2/week, 
3-4/week, >4/week 
Atrial fibrillation type CRF Paroxysmal, persistent, 
permanent 
Coexistent atrial flutter CRF Yes, no 
Prior electrical 
cardioversion  
CRF Yes, no 
Prior AF ablation CRF Yes, no 
Device CRF No, pacemaker, 
CRT/CRT-ICD, ICD 
Coronary artery disease  CRF Yes, no 
Stroke/TIA  CRF Yes, no 
Systemic embolism CRF Yes, no 
Heart failure CRF Yes, no 
Obstructive sleep apnea  CRF Yes, no 
Hypertension  CRF Yes, no 
Diabetes CRF Yes, no 
Peripheral artery disease  CRF Yes, no 
Renal failure CRF Yes, no 
Hyperthyroidism CRF Yes, no 
Hypothyroidism CRF Yes, no 
Pulmonary embolism/DVT CRF Yes, no 
Cancer CRF Yes, no; any malignoma. 
History of any bleed CRF Yes, no 
History of peptic ulcer CRF Yes, no 
Recurrent falls CRF Yes, no 
Oral anticoagulation CRF Yes, no 
Vitamin K antagonist CRF Marcoumar, Sintrom 
DOAC CRF Apixaban, Dabigatran, 
Edoxaban, Rivaroxaban 
Family history of 
hypertension 
CRF Yes, no/unknown 
Family history of diabetes CRF Yes, no/unknown 
Family history of obesity CRF Yes, no/unknown 
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Family history of coronary 
artery disease 
CRF Yes, no/unknown 
EHRA score CRF I, II, III, IV 
CRF, standardized case report form; CRT, cardiac resynchronization therapy; 
intracardial defibrillator; TIA, transient ischemic attack; DVT, deep vein thrombosis; 
DOAC, direct oral anticoagulants.  
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Table S3. Components of the Admit-AF Score 
Variable Points 
Age, y  
 <65 0 
 65-69 1 
 70-74 1 
 75-79 3 
 80-84 4 
 ≥85 6 
Previous PVI -3 
Hypertension     2 
Diabetes 3 
Coronary heart disease 2 
Prior stroke/TIA 3 
Heart failure 2 
Peripheral artery disease 3 
Renal failure 2 
Cancer 3 
Previous falls 4 
Abbreviations: PVI, pulmonary vein isolation; TIA, transient ischemic attack. 
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Table S4. Predictors of Hospital Admissions from Multivariable Models in the Validation Cohort (BEAT-AF, n=1300) 
 Model 
Predictors β Coefficient (SE) Adjusted HR (95% CI) P Value 
Age, year    
 <65 1 [Reference] NA NA 
 65-70 0.48 (0.11) 1.62 (1.30-2.02) <0.001 
 71-75 0.45 (0.13) 1.55 (1.21-1.98) 0.001 
 76-80 0.54 (0.13) 1.71 (1.33-2.19) <0.001 
 81-85 0.42 (0.16) 1.52 (1.12-2.08) 0.008 
 >85 0.48 (0.19) 1.61 (1.11-2.35) 0.013 
Previous PVI -0.05 (0.09) 0.95 (0.80-1.14) 0.60 
Hypertension -0.01 (0.09) 0.99 (0.84-1.17) 0.90 
Diabetes 0.29 (0.11) 1.34 (1.09-1.64) 0.006 
Coronary heart disease 0.01 (0.10) 1.01 (0.83-1.22) 0.95 
Prior stroke/TIA -0.19 (0.11) 0.82 (0.66-1.03) 0.09 
Heart failure 0.26 (0.10) 1.30 (1.08-1.57) 0.006 
Peripheral vascular disease 0.42 (0.14) 1.52 (1.15-2.01) 0.003 
Cancer 0.18 (0.10) 1.20 (0.99-1.44) 0.058 
Renal failure 0.08 (0.11) 1.08 (0.87-1.34) 0.48 
Previous falls 0.15 (0.14) 1.16 (0.88-1.54) 0.29 
Abbreviations: SE, standard error; HR, hazard ratio; NA, not applicable. 
The model includes all variables listed (age, previous PVI, hypertension, diabetes, 
coronary heart disease, prior stroke/TIA, heart failure, peripheral artery disease, renal 
failure, cancer, previous falls). 
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Table S5. Predictors of Hospital Admissions from Multivariable Model of Combined Cohorts (n=3687) 
 Model 
Predictors β Coefficient (SE) Adjusted HR (95% CI) P Value 
Age, year    
 <65 1 [Reference] NA NA 
 65-70 0.20 (0.09) 1.22 (1.03-1.45) 0.023 
 71-75 0.13 (0.09) 1.14 (0.95-1.36) 0.15 
 76-80 0.30 (0.19) 1.35 (1.13-1.62) 0.001 
 81-85 0.32 (0.10) 1.38 (1.12-1.69) 0.002 
 >85 0.54 (0.12) 1.72 (1.35-2.19) <0.001 
Previous PVI -0.10 (0.07) 0.91 (0.80-1.03) 0.14 
Hypertension 0.09 (0.06) 1.09 (0.97-1.23) 0.13 
Diabetes 0.31 (0.07) 1.36 (1.20-1.55) <0.001 
Coronary artery disease 0.07 (0.06) 1.08 (0.96-1.21) 0.21 
Prior stroke/TIA 0.08 (0.06) 1.08 (0.95-1.22) 0.24 
Heart failure 0.21 (0.06) 1.23 (1.09-1.38) 0.001 
Peripheral artery disease 0.31 (0.09) 1.36 (1.15-1.62) <0.001 
Cancer 0.27 (0.06) 1.31 (1.16-1.49) <0.001 
Renal failure 0.12 (0.06) 1.13 (0.99-1.28) 0.058 
Previous falls 0.28 (0.09) 1.32 (1.11-1.57) 0.001 
Abbreviations: SE, standard error; HR, hazard ratio; NA, not applicable. 
The model includes all variables listed (age, previous PVI, hypertension, diabetes, 
coronary heart disease, prior stroke/TIA, heart failure, peripheral artery disease, renal 
failure, cancer, previous falls). 
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Figure S1  
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Figure S3 
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Figure S4 
 
1-Year Risk 
A Derivation Cohort 
 
B Validation Cohort 
 
3-Year Risk 
C Derivation Cohort 
 
D Validation Cohort 
 
 Model 
Intercept 0.07 
Slope 0.99 
C statistic 0.64 (0.61-0.66) 
 
 Model 
Intercept 0.01 
Slope 0.99 
C statistic 0.59 (0.56-0.63) 
 
 Model 
Intercept 0.00 
Slope 1.00 
C statistic 0.63 (0.61-0.65) 
 
 Model 
Intercept 0.01 
Slope 1.00 
C statistic 0.59 (0.57-0.61) 
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Figure S5 
 A 1-Year Risk B 3-Year Risk 
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Figure legends 
Figure S1 Formation of the Derivation and Validation Cohorts  
Figure S2 Visual Inspection of the Path of Variable Selection Using LASSO 
Figure S3 Variables selected by LASSO (N=11) 
Figure S4 Calibration Plots with C Statistics for the Predicted Versus 
Observed 1-year and 3-year Hospital Admission Risk of the 
Prediction Model 
Derivation cohort (n=2387) and validation cohort (n=1300). Error bars 
indicate 95% confidence intervals. Red line connects the estimates of 
each decile. 
Figure S5 Decision Curve Analysis for the Admit-AF Score 
The net clinical benefit using the risk prediction models to guide clinical 
decision in relation to assuming that no one is at risk (x axis) or that all 
are at risk (y axis) for hospital admission. The x axis of different decision 
thresholds is plotted against the y axis (N=3687). 
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Abstract 
Background: A high burden of cardiovascular comorbidities puts patients with atrial 
fibrillation (AF) at increased risk for being admitted to the hospital. However, whether 
psychosocial factors may contribute to the high rate of unplanned hospital admissions 
remains unclear.  
Objectives: To assess the relationships of psychosocial factors with the incidence of 
hospital admissions in patients with AF. 
Methods: We prospectively evaluated associations of psychosocial factors (i.e., 
marital status, education, depression and health perception) with the incidence of 
hospital admission in 2358 patients with AF from the Swiss Atrial Fibrillation Cohort 
(Swiss-AF). The primary outcome was defined as time to first unplanned all-cause 
hospital admission, while secondary outcomes were time to first cardiovascular and 
non-cardiovascular admissions. Associations of psychosocial factors with the 
incidence of hospital admission were tested by multivariable Cox regression models. 
Patients were categorized into three groups according to their overall burden of 
psychosocial conditions, and compared using multivariable Cox models. 
Results: During a median follow-up of 2.0 years, 877 (37%) patients had at least one 
all-cause hospital admission, while 367 (16%) patients were hospitalized for 
cardiovascular and 618 (26%) for non-cardiovascular causes. The highest risk of all-
cause hospital admission was observed in single patients (adjusted hazard ratio [aHR], 
1.35; 95% confidence interval [CI], 1.05-1.75) and divorced patients (aHR, 1.26; 95% 
CI, 1.03-1.54) and in those who reported low health perception (aHR, 1.40; 95% CI, 
1.21-1.62). For cardiovascular and non-cardiovascular admissions, only low health 
perception was a strong predictor. When patients were categorized according to their 
burden of psychosocial conditions, adjusted hazard ratios for all-cause hospital 
admission were 1.83 (95% CI, 1.47-2.29) for single or divorced patients with low health 
perception relative to patients without. Adjusted hazard ratio for patients who were 
single or divorced, or had low health perception compared to patients who had none 
was 1.35 (95% CI, 1.16-1.56). Similar associations were indicated for cardiovascular 
and non-cardiovascular admissions.  
Conclusions: Psychosocial factors, namely marital status and health perception, are 
predictive of hospital admissions in AF patients. Hence, treatment strategies may profit 
from complementary psychosocial interventions in this patient population. 
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Introduction 
The prevalence of atrial fibrillation (AF) is increasing and expected to affect nearly 18 
million Europeans in the future.1 Patients with AF have multiple comorbidities and a 
high risk of stroke and death,2-4 which puts them at increased risk of being admitted to 
the hospital.5 Although most hospital admissions are essentially triggered by medical 
disorders, non-medical factors may be crucial as well.  
It is well-established that factors that promote health are not only lifestyle modifications 
and medical treatments, but also a patient’s social and psychological conditions (i.e., 
marital status, education, mental health).6 These psychosocial factors were shown to 
affect the risk of cardiovascular disease,7,8 and evidence suggests that the effects are 
comparable in strength to those associated with physical activity, smoking, or alcohol 
use.9,10 Prior studies addressed the relationships of psychosocial risk factors with 
incident AF and heart failure admissions.11-13 It showed that among AF patients, those 
who had low social status, low education, or low household income levels 
demonstrated a higher risk of mortality as compared to individuals without such 
psychosocial constrains.14  
However, only very little is known about how psychosocial factors may affect the risk 
of unplanned hospital admissions in AF populations. For instance, patients with low 
social support may be less able to cope with health conditions and life crises, which 
may increase their tendency to seek medical hospital care. If there is evidence in 
support of this notion, it may sensitize physicians to advise psychosocial interventions. 
Given that hospital admissions are strong drivers of healthcare expenditures, such 
evidence may imply new strategies to reduce costs related to hospital admission rates. 
We therefore aimed to investigate the prevalence of psychosocial factors and their 
effects on hospital admissions in a comprehensive cohort of clinically well-
characterized patients with AF.  
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Methods 
Study population 
The Swiss Atrial Fibrillation Cohort (Swiss-AF) is a large prospective cohort study of 
2415 patients with diagnosed AF, recruited between 2014 and 2017 across 14 centers 
in Switzerland. Details of the study design and first results have been published 
previously.15,16 Patients were enrolled if they had documented AF (at least 1 
electrocardiogram recording showing AF) and were ≥65 years of age. Patients were 
excluded if they had only short, reversible AF episodes (i.e., AF occurring after cardiac 
surgery) or if they were unable to give informed consent. Of the 2415 patients included, 
57 (2.4%) were excluded from the present analysis due to drop-out or consent 
withdrawal (n=28, 1.2%) or missing values regarding psychosocial factors (n=29, 
1.2%). Thus, the analyses included a total of 2358 patients. The study protocol was 
approved by the local ethics committees, and written informed consent was obtained 
from all participants. 
Procedures 
Demographic and clinical information were collected using standardized case report 
forms and validated questionnaires. Yearly follow-up visits were performed by local 
study personnel, either face-to-face or by phone calls, to collect patient characteristics, 
clinical measures and outcome events. 
Marital status and education level were defined as social factors, and presence of 
depression and health perception were considered as the psychological component. 
Marital status was requested in terms of married, single, divorced or widowed. 
Education level was evaluated using the sum of completed years at school, high school 
or college, and defined as primary or less (less than compulsory education curriculum: 
≤6 years), secondary (high school or similar: 6 to ≤12 years) and college or university 
(college or university degree: >12 years of education). Depression and depressive 
symptoms were measured using the Geriatric Depression Scale (GDS),17,18 with a total 
point score ranging from 0 to 15, and a total score of >5 points was taken to indicate 
depression. Health perception was self-assessed by patients indicating their current 
state of health using a visual analogue scale (VAS) ranging from 0 (worst) to 100 (best). 
The VAS used in this study was based on the EuroQol VAS and has been validated 
for AF patients.19,20 For the purpose of the present analyses, the median was set for 
the threshold of low (<75%) versus high (≥75) health perception. 
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Outcomes 
The primary outcome of this study was time to first all-cause hospital admission, 
defined as any unplanned admission leading to at least 1 overnight stay. Secondary 
outcomes were time to first cardiovascular and non-cardiovascular hospital 
admissions, with cardiovascular admissions being defined as admission due to heart 
failure, stroke or transient ischemic attack (TIA), myocardial infarction, bleeding, or 
deep vein thrombosis. Repeated admissions were not counted. The occurrence and 
type of events were assessed at yearly follow-up examinations (i.e., on-site visit, phone 
call, or information gathered from the family doctor). 
Statistical analysis 
Baseline characteristics are presented as means with standard deviation (SD) for 
continuous variables and as counts (percentages) for categorical variables. Incidence 
rates and 95% confidence intervals (CI) for primary and secondary outcomes were 
calculated per 100 patients-years of follow-up. Kaplan-Meier plots were used to 
describe the cumulative incidence of hospital admissions. We constructed Cox 
proportional hazards models to test the associations of psychosocial factors with the 
risk of hospital admission, adjusting for cardiovascular and non-cardiovascular 
covariates. These covariates included age, sex, body mass index (BMI), history of 
hypertension, diabetes, coronary heart disease, prior stroke or transient ischemic 
attack (TIA), heart failure, peripheral vascular disease, renal failure, cancer, and 
previous falls.  
We then constructed a combined multivariable model including all psychosocial factors 
to determine the strongest predictors for all-cause hospital admissions. Multivariable 
and combined models included 2349 patients due to missing data of 9 patients (0.4 
%). To investigate the proportional hazards assumption, we calculated Schoenfeld 
residuals.21  
To evaluate the overall burden of psychosocial factors and their impact on hospital 
admissions, we used the variables that were associated with all-cause hospital 
admission from the combined model, and categorized patients according to the 
presence of these factors into three groups. The groups were compared using 
multivariable Cox models, adjusted for the same covariates as listed above, and tested 
for trend of the survivor function across groups. 
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All analyses were performed using Stata, version 13 (StataCorp. 2013. College 
Station, TX: StataCorp LP). 
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Results 
Baseline characteristics are shown in Table 1. Of the 2358 patients included in this 
analysis, mean age was 73.2 (SD, 8.5) years, and 639 (27.1%) were women. 
Regarding the marital status, 1582 (67.1%) were married, 156 (6.6%) were single, 287 
(12.2%) were divorced, and 333 (14.1%) were widowed. Two hundred and seventy six 
patients (11.7%) had primary or less education, 1171 (49.7) had secondary education, 
and 911 (38.6%) had college or university degree. Depression was present in 99 
(4.2%) patients and median health perception was 75% (interquartile range [IQR], 
60%-85%). 
During a median of 2.0 (IQR, 1.0-3.0) years of follow-up, 877 (37%) patients had at 
least one hospital admission, with an incidence of 19.0 per 100 patient-years (95% 
confidence interval [CI], 17.8-20.3). Over the same follow-up time, 367 (16%) patients 
were hospitalized for cardiovascular and 618 (26%) for non-cardiovascular causes, 
with incidence rates of 6.9 and 13.4 per 100 person-years, respectively. Tables S1 in 
the Supplement shows the number of events and incidence rates for all-cause, 
cardiovascular and non-cardiovascular hospital admissions stratified by psychosocial 
factors and health perception.  
Patients who were not married, had secondary education, symptoms of depression, or 
exhibited low health perception a higher risk of all-cause hospital admission (Table 2). 
In multivariable analyses, patients who were single (adjusted hazard ratio [aHR], 1.38; 
95% CI, 1.07-1.78) or divorced (aHR, 1.26; 95% CI, 1.03-1.55) and those who had a 
low health perception (aHR, 1.43; 95% CI, 1.24-1.62) showed an increased risk of all-
cause hospital admission (Table 2). These findings persisted in the combined model 
(all P<0.05) (Table 2).  
For cardiovascular hospital admissions, only low health perception remained strongly 
associated with the outcome in the combined multivariable model (aHR, 1.47; 95% CI, 
1.18-1.83) (Table S2 in the Supplement). Similar for non-cardiovascular admissions, 
only low health perception remained associated with the outcome in the combined 
model (aHR, 1.39; 95% CI, 1.17-1.64) (Table S3 in the Supplement).  
From the combined model, being single or divorced and having low health perception 
were identified as predictors for all-cause hospital admissions and patients were 
categorized accordingly. Cumulative incidences of all-cause hospital admission across 
categories are presented in Figure 1. Hazard ratios for the risk of all-cause hospital 
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admission were 1.83 (95% CI, 1.47-2.29) for patients who were single or divorced and 
had low health perception versus patients who had none of these factors. Patients who 
were either single or divorced, or had low health perception had a higher risk of 
admission as compared to those without any of these factors (aHR, 1.36; 95% CI, 1.14-
1.61) (Table 4).  
Kaplan-Meier curves for cardiovascular and non-cardiovascular hospital admissions 
were plotted according to marital status and health perception (Figures S1A and S1B 
in the Supplement). Patients who were single or divorced and had low health 
perception had a higher risk of cardiovascular admission as compared to patients 
without any of these factors (aHR, 1.90; 95% CI, 1.36-2.65). Patients who were either 
single or divorced, or showed low health perception exhibited a higher risk 
cardiovascular admission than patients without these factors (aHR, 1.38; 95% CI, 1.09-
1.74). Similar for non-cardiovascular admissions, hazard ratios were 1.66 (95% CI, 
1.27-2.18) for patients who were single or divorced and had low health perception 
relative to those exhibiting none of these factors. Patients who were either single or 
divorced, or showed low health perception indicated a higher risk of non-cardiovascular 
admission as compared to patients without such psychosocial conditions (aHR, 1.26; 
95% CI, 1.03-1.53) (Table 3). 
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Discussion 
The present study investigated the relationships between psychosocial factors and the 
risk of unplanned hospital admissions in patients with AF. Several important findings 
emerged. First, the incidence of hospital admission was high in this patient population, 
with nearly two-thirds of admissions being due to non-cardiovascular causes. Second, 
patients who were single or divorced, or indicated a low health perception had a 
significantly higher risk of hospital admission. This risk was even higher among patients 
to whom both of these psychosocial conditions applied, suggesting that the overall 
burden of psychosocial conditions matters.   
Our study showed that patients who were single or divorced revealed a higher risk of 
all-cause hospital admission relative to those who were married. Consistently, previous 
studies showed higher admission rates for unmarried relative to married individuals 
from non-AF population.22,23 These findings are in line with the notion that relative to 
those living alone (single, divorced), patients who have close relationships to others 
can rely on better social support, acting to decrease psychological distress,24 and may 
therefore show increased needs for institutionalized hospital care.25 
Our results indicated that the risk of all-cause hospital admission was associated with 
subjective evaluations of health, which was also indicated for cardiovascular and non-
cardiovascular admissions. Specifically, patients who felt in relatively good health 
conditions were generally less prone to seek for hospital care relative to those who felt 
less healthy. Evidence from studies of non-AF populations showed that patients who 
reported poor or fair health conditions exhibited an up to five time higher risk of hospital 
admission or death as compared to those reporting excellent or good health.26,27 
Previous studies suggested that self-efficacy is a key predictor of heart failure hospital 
admission and all-cause death.28 One may assume that social support and help of 
close others strengthen self-efficacy beliefs, acting as a buffer of distress due to 
medical illness, which prevents patients with high social support from striving for 
hospital admission. This account corresponds to the high admission rates of unmarried 
patients observed in the present study. Moreover, low evaluations of health have often 
been reported for AF population.29 
In an attempt to identify patients at high risk of hospital admissions, we stratified 
patients into three groups according to their burden of psychosocial conditions. Results 
showed that the risk of all-cause hospital admission increased with increasing burden 
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of psychosocial factors (see Table 3, Figure 1). Similar effects were observed for 
cardiovascular and non-cardiovascular admissions (Table 3, Figure S1A and S1B in 
the Supplement). Further studies are required to highlight the impact of social support 
and self-efficacy on admission risk, and to better understand how the overall burden of 
distinct psychosocial factors may influence this adverse outcomes in AF patients.   
Overall, the present results may also be informative for clinical purposes. Greater 
awareness of the patients’ psychosocial conditions may help clinicians to intervene 
more sensitively and to be more responsive to the specific support needs that are 
activated by illness. Interventions may thus include to improve the patient’s social 
relations and to strengthen their self-efficacy in face of illness, which may imply 
psychosocial counselling, self-help group assignment, or psychotherapy. To highlight 
this issue, future studies should include direct measures of social support. Also, effects 
of psychosocial treatment as complementary strategy of AF-related medical treatment 
should be addressed.  
Strengths and Limitations 
This study is, to our best knowledge, the first to highlight associations of psychosocial 
factors and hospital admissions in patients with AF, based on a comprehensive 
multicenter population-based cohort of clinically well-characterized patients. However, 
some limitations emerge. First, the variables representing psychosocial factors were 
collected based on availability in the cohort data set. However, additional factors, such 
as income or measures of social deprivation, may matter. Second, we assessed time 
to first hospital admission, and ignored any repeated admissions. Lastly, our results 
stem from a national cohort of AF patients in Switzerland, implying limited 
generalizability. 
In conclusion, our findings suggest that low social support and low health evaluations 
are associated with an increased risk of hospital admission in AF patients. These 
findings may sensitize clinicians to identify AF patients who may benefit from 
complementary intervention strategies aiming to improving psychosocial conditions. 
Enhancing psychosocial conditions may even contribute to reduced health care costs 
due to decreased needs for hospital medical care in this patient population.   
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Figure legends 
Figure 1  Cumulative incidence of all-cause hospital admission 
according to the burden of marital status and health perception 
Abbreviations: HP, health perception 
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Table 1 Baseline characteristics  
Characteristic 
Overall 
(N=2358) 
Age, mean (SD), y 73.2 ± 8.5 
Female sex 639 (27.1) 
Marital status  
 Married 1582 (67.1) 
 Single 156 (6.6) 
 Divorced 287 (12.2) 
 Widowed 333 (14.1) 
Education  
 Primary or less 276 (11.7) 
 Secondary 1171 (49.7) 
 College, or university 911 (38.6) 
Depression or depressive symptoms 99 (4.2) 
Health perception, median (IQR), % 75 (60-85) 
Atrial fibrillation type  
 Paroxysmal 1059 (44.9) 
 Persistent 694 (29.4) 
 Permanent 605 (25.7) 
Body mass index, median (IQR), kg/m2 27.0 (24.4-30.4) 
Comorbidities  
 Hypertension 1640 (69.6) 
 Diabetes 399 (16.9) 
 Coronary artery disease 721 (30.6) 
 Stroke/TIA 467 (19.8) 
 Heart failureb 608 (25.8) 
 Peripheral vascular disease 186 (7.9) 
 Bleeding 370 (15.7) 
CHA2DS2-VASc score, median (IQR)c 3.0 (2.0-5.0) 
Oral anticoagulation 2157 (90.4) 
 Vitamin K antagonist 932 (39.5) 
 Direct oral anticoagulants 1197 (50.8) 
Antiplatelet therapyd 468 (19.9) 
Abbreviations: IQR= interquartile range; CHA2DS2-VASc=congestive heart 
failure, hypertension, age 75≥ years (2 points), diabetes, prior stroke or TIA or 
thromboembolism (2 points), vascular disease, age 65 to 74 years, female sex. 
Bleeding= major bleeding or clinically relevant non-major bleeding; 
a N=16 missing values; b N=2 missing values; c N=3 missing values; d N=4 
missing values. 
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Table 2 Association of psychosocial factors and health perception with all-cause hospital admission 
 All-cause hospital admission      
Variables 
Events/ 
No. at risk 
Unadjusted 
HR (95% CI) P value 
Adjusted 
HR (95% CI)* P value 
Combined 
adjusted 
HR (95% CI)† P value 
Marital status        
  Married 560/1582 1 [Reference]  1 [Reference]  1 [Reference]  
  Single 69/156 1.32 (1.03-1.70) 0.03 1.38 (1.07-1.78) 0.01 1.35 (1.05-1.75) 0.02 
  Divorced 118/287 1.24 (1.01-1.51) 0.04 1.26 (1.03-1.55) 0.02 1.26 (1.03-1.54) 0.03 
  Widowed 130/333 1.24 (1.02-1.50) 0.03 1.05 (0.85-1.29) 0.65 1.04 (0.85-1.28) 0.71 
Education 
     
  
  College, or university 308/911 1 [Reference]  1 [Reference]  1 [Reference]  
  Secondary 463/1171 1.20 (1.04-1.39) 0.01 1.14 (0.98-1.32) 0.08 1.15 (1.00-1.34) 0.05 
  Primary or less 106/276 1.18 (0.94-1.47) 0.14 1.09 (0.86-1.38) 0.48 1.04 (0.85-1.28) 0.50 
Depression 
     
  
  No 828/2259 1 [Reference]  1 [Reference]  1 [Reference]  
  Yes  49/99 1.53 (1.14-2.04) 0.004 1.23 (0.91-1.65) 0.17 1.12 (0.83-1.51) 0.46 
Health perception 
     
  
  High: ≥75% 403/1334 1 [Reference]  1 [Reference]  1 [Reference]  
  Low: <75% 474/1024 1.81 (1.58-2.07) <0.001 1.43 (1.24-1.65) <0.001 1.41 (1.22-1.62) <0.001 
Data are presented as hazard ratio (HR) with 95% confidence intervals (CI). 
*Models were adjusted for age, sex, body mass index, hypertension, diabetes, coronary heart disease, prior stroke/TIA, heart failure, peripheral 
vascular disease, renal failure, cancer, and previous falls. 
† Model was combined and adjusted for age, sex, body mass index, hypertension, diabetes, coronary heart disease, prior stroke/TIA, heart 
failure, peripheral vascular disease, renal failure, cancer, and previous falls. 
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Table 3 Risk of all-cause hospital admission according to marital status and health perception  
Outcome 
No. of Events/ 
Patients Incidencea  
Adjusted  
HR (95% CI)* P value P trend 
All-cause hospital admission      
 None 330/1112 14.0 (12.6-15.6) 1 [Reference]  <0.001 
 Single/divorced or low health perception 433/1025 23.0 (20.9-25.3) 1.35 (1.16-1.56) <0.001  
 Single/divorced and low health perception 114/221 30.6 (25.5-36.8) 1.83 (1.47-2.29) <0.001  
Cardiovascular hospital admission      
 None 125/1112 4.7 (4.0-5.6) 1 [Reference]  <0.001 
 Single/divorced or low health perception 188/1025 8.4 (7.3-9.7) 1.38 (1.09-1.74) 0.007  
 Single/divorced and low health perception 54/221 11.7 (8.9-15.2) 1.90 (1.36-2.65) <0.001  
Non-cardiovascular hospital admission      
 None 234/1112 9.3 (8.2-10.6) 1 [Reference]  <0.001 
 Single/divorced or low health perception 310/1025 14.9 (13.4-16.7) 1.37 (1.15-1.64) <0.001  
 Single/divorced and low health perception 74/221 17.2 (13.7-21.5) 1.66 (1.27-2.18) <0.001  
a Incidence per 100 patient-years of follow-up (95% CI) 
*Adjusted for age, sex, body mass index, hypertension, diabetes, coronary heart disease, prior stroke/TIA, heart failure, peripheral 
vascular disease, renal failure, cancer, and previous falls. 
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Figure 1 Cumulative incidence of all-cause hospital admission according to 
the burden of marital status and health perception 
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Table S1 Incidence of hospital admissions according to psychosocial factors 
 
All-cause  
hospital admission  
Cardiovascular  
hospital admission  
Non-cardiovascular  
hospital admission 
Psychosocial risk factors 
Events/ 
No. of patients Incidencea  
Events/ 
No. of patients Incidencea  
Events/ 
No. of patients Incidencea 
Marital status         
  Married 560/1582 17.5 (16.2-19.1)  233/1582 6.3 (5.6-7.2)  391/1582 11.3 (10.2-12.5) 
  Single 69/156 23.5 (18.6-29.8)  29/156 8.4 (5.9-12.1)  48/156 14.7 (11.1-19.5) 
  Divorced 118/287 21.9 (18.3-26.2)  53/287 8.3 (6.3-10.8)  80/287 13.5 (10.9-16.8) 
  Widowed 130/333 22.2 (18.7-26.4)  52/333 7.5 (5.7-9.9)  99/333 15.5 (12.8-18.9) 
Education 
  
      
  College, or university 308/911 16.9 (15.1-18.9)  133/911 6.3 (5.4-7.6)  217/911 11.0 (9.6-12.6) 
  Secondary 463/1171 20.4 (18.7-22.4)  194/1171 7.3 (6.3-8.4)  326/1171 13.2 (11.9-14.7) 
  Primary or less 106/276 20.2 (16.7-24.4)  41/276 6.5 (4.8-8.9)  75/276 13.0 (10.4-16.3) 
Depression 
  
      
  No 828/2259 18.6 (17.4-20.0)  345/2259 6.7 (6.0-7.5)  585/2259 12.1 (11.2-13.1) 
  Yes  49/99 30.0 (17.4-38.3)  22/99 10.1 (6.7-15.4)  33/99 17.5 (12.4-24.6) 
Health perception 
  
      
  High: ≥75% 403/1334 14.3 (13.0-15.8)  153/1334 4.8 (4.1-5.6)  288/1334 9.6 (8.6-10.8) 
  Low: <75% 474/1024 26.4 (24.2-28.9)  214/1024 9.8 (8.6-11.2)  330/1024 16.3 (14.7-18.2) 
a Incidence per 100 patient-years of follow-up (95% CI)  
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Table S2 Association of psychosocial factors with cardiovascular hospital admission 
 Cardiovascular hospital admission     
Variables 
Events/ 
No. at risk 
Unadjusted 
HR (95% CI) P value 
Adjusted 
HR (95% CI)* P value 
Combined 
adjusted 
HR (95% CI)† P value 
Marital status        
  Married 233/1582 1 [Reference]  1 [Reference]  1 [Reference]  
  Single 29/156 1.30 (0.89-1.92) 0.18 1.36 (0.92-2.01) 0.12 1.31 (0.89-1.95) 0.17 
  Divorced 53/287 1.28 (0.95-1.73) 0.10 1.31 (0.97-1.78) 0.08 1.29 (0.95-1.75) 0.10 
  Widowed 52/333 1.14 (0.84-1.54) 0.85 1.03 (0.74-1.42) 0.17 1.03 (0.75-1.42) 0.19 
Education  
    
  
  College, or university 133/911 1 [Reference]  1 [Reference]  1 [Reference]  
  Secondary 194/1171 1.14 (0.91-1.42) 0.25 1.05 (0.84-1.32) 0.67 1.06 (0.85-1.34) 0.59 
  Primary or less 41/276 1.02 (0.72-1.45) 0.89 0.95 (0.65-1.38) 0.77 0.94 (0.65-1.37) 0.76 
Depression  
    
  
  No 345/2259 1 [Reference]  1 [Reference]  1 [Reference]  
  Yes  22/99 1.51 (0.98-2.31) 0.06 1.23 (0.79-1.91) 0.36 1.12 (0.72-1.74) 0.63 
Health perception  
    
  
  High: ≥75% 153/1334 1 [Reference]  1 [Reference]  1 [Reference]  
  Low: <75% 214/1024 1.97 (1.60-2.43) <0.001 1.47 (1.18-1.83) <0.001 1.44 (1.16-1.80) 0.001 
Data are presented as hazard ratio (HR) with 95% confidence intervals (CI). 
*Models were adjusted for age, sex, body mass index, hypertension, diabetes, coronary heart disease, prior stroke/TIA, heart failure, peripheral 
vascular disease, renal failure, cancer, and previous falls. 
† Model was combined and adjusted for age, sex, body mass index, hypertension, diabetes, coronary heart disease, prior stroke/TIA, heart 
failure, peripheral vascular disease, renal failure, cancer, and previous falls. 
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Table S3 Association of psychosocial factors and health perception with non-cardiovascular hospital admission 
 Non-cardiovascular hospital admission     
Variables 
Events/ 
No. at risk 
Unadjusted 
HR (95% CI) P value 
Adjusted 
HR (95% CI)* P value 
Combined 
adjusted 
HR (95% CI)† P value 
Marital status        
  Married 391/1582 1 [Reference]  1 [Reference]  1 [Reference]  
  Single 48/156 1.28 (0.95-1.73) 0.10 1.31 (0.97-1.78) 0.08 1.29 (0.95-1.75) 0.11 
  Divorced 80/287 1.19 (0.93-1.51) 0.16 1.23 (0.96-1.57) 0.10 1.21 (0.95-1.55) 0.12 
  Widowed 99/333 1.34 (1.07-1.67) 0.01 1.10 (0.87-1.40) 0.41 1.09 (0.86-1.39) 0.47 
Education  
    
  
  College, or university 217/911 1 [Reference]  1 [Reference]  1 [Reference]  
  Secondary 326/1171 1.19 (1.01-1.42) 0.04 1.14 (0.95-1.36) 0.15 1.15 (0.96-1.37) 0.12 
  Primary or less 75/276 1.18 (0.90-1.53) 0.23 1.07 (0.81-1.41) 0.66 1.05 (0.79-1.39) 0.72 
Depression  
    
  
  No 585/2259 1 [Reference]  1 [Reference]  1 [Reference]  
  Yes  33/99 1.42 (0.99-2.01) 0.051 1.19 (0.83-1.71) 0.33 1.09 (0.76-1.56) 0.66 
Health perception  
    
  
  High: ≥75% 288/1334 1 [Reference]  1 [Reference]  1 [Reference]  
  Low: <75% 330/1024 1.67 (1.43-1.96) <0.001 1.40 (1.19-1.66) <0.001 1.39 (1.17-1.64) <0.001 
Data are presented as hazard ratio (HR) with 95% confidence intervals (CI). 
*Models were adjusted for age, sex, body mass index, hypertension, diabetes, coronary heart disease, prior stroke/TIA, heart failure, peripheral 
vascular disease, renal failure, cancer, and previous falls. 
† Model was combined and adjusted for age, sex, body mass index, hypertension, diabetes, coronary heart disease, prior stroke/TIA, heart 
failure, peripheral vascular disease, renal failure, cancer, and previous falls. 
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Figure S1 Probability of cardiovascular and non-cardiovascular hospital admissions stratified by psychosocial burden 
groups 
A Cardiovascular hospital admission 
 
B Non-cardiovascular hospital admission 
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7. SUMMARY OF MAIN FINDINGS 
7.1. Incidence and causes of hospital admission in atrial fibrillation 
The pooled incidence of all-cause hospital admission was estimated to be 43.2 per 100 
person-years. Cardiovascular admission were more common than non-cardiovascular 
(pooled incidence 26.3 vs 15.7 per 100 person-years). In meta-regression analyses 
including several variables, older age and prevalence of COPD were associated with 
an increased rate of all-cause hospital admissions. Patients with AF have a high risk 
of being admitted to the hospital, both for cardiovascular and non-cardiovascular 
causes. 
 
7.2. Risk score for predicting hospital admissions in atrial 
fibrillation 
In the derivation cohort (Swiss-AF), 891 patients (37.3%) were admitted to the hospital 
over a median follow-up of 2.0 years (incidence 19.1 per 100 person-years). 
Cardiovascular admissions occurred in 377 (15.8%) and non-cardiovascular in 629 
(26.4%). Overall, 11 variables were selected by LASSO that were independently 
associated with the risk of hospital admission: age, previous PVI, hypertension, 
diabetes, coronary heart disease, prior stroke or TIA, heart failure, peripheral vascular 
disease, cancer, renal failure and previous falls. The Admit-AF score achieved a c-
index of 0.64 for 1-year predicted risk and 0.63 for 3-year hospital admission risk in the 
derivation cohort. In the validation cohort (BEAT-AF), 719 patients (55.3%) were 
admitted to the hospital after a median follow-up of 1.9 years (cumulative incidence 
26.1 per 100 person-years). Cardiovascular and non-cardiovascular admissions 
occurred in 357 (27.5%) and 514 (39.5%), respectively. The Admit-AF score yielded a 
c-index of 0.59 for the 1-year risk and 0.59 for 3-year hospital admission risk. Model 
calibration for 1-year and 3-year risk was accurate in the derivation cohort and 
remained well calibrated in the validation cohort. 
 
7.3. Psychosocial factors for hospital admissions in atrial 
fibrillation 
Of the 2,358 patients included in this analysis, 877 (37%) had at least one all-cause 
hospital admission, 367 (16%) patients were hospitalized for cardiovascular and 618 
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(26%) for non-cardiovascular causes after a median follow-up of 2.0 years. Patients 
who were single or divorced, and those who had a low health perception had the 
highest risk of all-cause hospital admission. For cardiovascular and non-cardiovascular 
admissions, only low health perception remained strongly associated with the 
secondary outcomes. When patients were categorized according to their burden of 
psychosocial conditions, adjusted hazard ratios for all-cause hospital admission were 
1.83 (95% CI, 1.47-2.29) for single or divorced patients with low health perception 
compared to patients without. Adjusted hazard ratio for patients who were single or 
divorced, or had low health perception compared to patients who had none of these 
psychosocial conditions was 1.35 (95% CI, 1.16-1.56). Similar associations were 
identified for cardiovascular and non-cardiovascular admissions.  
 
The main findings are summarized in Figure 4: 
  
Figure 4 Illustration of the main investigations of the project. 
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8. DISCUSSION 
In the following sections the findings of the three works of this PhD project will be 
discussed in light of the current literature and important potential implications will be 
emphasized. In addition, the discussion will critically evaluated the methodological 
aspects of the three works, including the strengths and limitations of this project. The 
potential implications of this project for future research will be outlined to further 
increase the knowledge in this important research field. Lastly, the specific 
contributions of the PhD student will be presented at the end of the discussion. 
 
8.1. Specific discussion on the topic 
8.1.1. Hospital admission and its consequence 
There is a large body of evidence indicating that hospital admissions are increasing 
and that they are an important risk factor for adverse events. Extensive research has 
been conducted to examine the causes for readmissions in patients without AF who 
were discharged from the hospital. The researchers found that approximately 25% of 
all readmissions occurring within 30 days after discharge are preventable.78 Also, 
patients who have recently been hospitalized have an increased risk for adverse 
events, such as heart failure, acute myocardial infarction, pneumonia and death.79 
These observations underscore that hospital admissions may be seen as a marker for 
patients who may have worse prognosis because of the underlying severity of illness. 
Consequently, preventing unnecessary admissions could have a positive impact on 
the overall risk of adverse outcomes in these patients. 
Several published studies that assessed factors associated with hospital admission 
focused only on specific patient populations, such as patients with specific diagnosis 
such as HIV, heart failure, dementia or psychiatric disease.80-82 This complicates the 
ability to compare admission rates and associated risk factors, and further limits the 
possibility for policy makers to establish and implement preventive interventions 
amongst a general population of patients. 
From an economic point of view, hospital admissions represents the largest driver of 
health care costs, regardless of the examined patient populations. This is also true for 
AF populations. Overall, the estimated care costs of hospitalized AF patients are 9 to 
23-fold greater than for those without AF.83 In the Cardiovascular Health Study and the 
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Framingham Heart Study, investigators matched patients with newly diagnosed AF to 
controls free from AF.84 They found that AF was associated with large incremental 
hospital and clinical care costs. The authors further suggested that the expected 
increase in AF prevalence worldwide may bring an increase in health care expenses 
which will pose a substantial burden on our health care systems. 
There are also individual economic consequences for the patients who are admitted to 
the hospital. Reports from the United States indicate that individuals face considerable 
economic consequences of hospital admissions mainly through the impact on labor 
earnings.85 It has been estimated that earnings decline associated with hospital 
admissions are similar to the existing estimates of the earnings consequences of job 
displacement. However, such data have not been investigated in AF populations, but 
it can be speculated that AF patients may also face similar earning consequences.  
Taken together, hospital admissions have a substantial impact on the patient’s 
prognosis and are associated with complications and economic consequences for the 
individual patient, but also for the health care system and our societies.  
8.1.2. Incidence of hospital admissions 
Patients with AF have multiple cardiovascular and non-cardiovascular comorbidities 
and therefore have an increased risk of various adverse outcome events, such as 
stroke and heart failure. Given this, these patients are particularly at high risk of being 
admitted to the hospital. Based on the results of our meta-analysis which included 35 
studies with 311314 AF patients, the pooled incidence of all-cause hospital admission 
was very high, with 43.7 (95% CI, 38.5-48.9) per 100 person-years. In our two cohorts 
we observed an incidence of all-cause hospital admission of 19.1 (95% CI, 17.9-20.4) 
per 100 person-years in Swiss-AF and an incidence of 26.1 (95% CI, 24.2-28.1) per 
100 person-years in BEAT-AF. The lower incidence rates in Swiss- and BEAT-AF 
explained by the stable condition of our patients compared to those in other studies 
and may reflect that most patients are well treated medically. Another reason could be 
that hospital admissions have not been evaluated similarly. Indeed, we observed in 
our meta-analysis that there was substantial between-study heterogeneity. It is 
possible that studies reported hospital admissions differently, which could have 
contributed to the different reported admission incidences. Also, although all studies 
included patients with AF, information about comorbidities is not fully available and it 
could be that differences in burden of comorbidities may have led to the observed 
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differences in incidence rates. This difference was further examined in our meta-
analysis by performing subgroup and meta-regression analyses. Interestingly, it seems 
that among AF populations that had a high prevalence of COPD, patients had a 
significant higher overall incidence for all-cause hospital admission. The impact of AF 
in patients with COPD has been investigated in several publications.86 The results 
showed that the incidence of hospital admission for AF was twice as high in COPD 
patients compared to those without AF. Also, they found that COPD patients with 
concomitant AF have a significantly higher prevalence of comorbidities as compared 
to patients who had COPD alone. Also, increasing age was associated with an overall 
higher incidence rate for all-cause hospital admission, which is not unexpected.  
In our meta-analysis, 24 studies provided information on the rates of cardiovascular 
and non-cardiovascular admissions. The pooled incidence of cardiovascular and non-
cardiovascular admissions was 26.3 (95% CI, 22.7-29.9) and 15.7 (95% CI, 12.5-18.9) 
per 100 person-years, respectively. In Swiss-AF the observed incidence of 
cardiovascular admission was 7.0 (95% CI, 6.3-7.7) per 100 person-years and it was 
10.3 (95% CI, 9.3-11.4) per 100 person-years in BEAT-AF. The incidence of non-
cardiovascular admission in Swiss-AF was 12.4 (11.5-13.4) per 100 person-years and 
16.2 (14.9-17.7) per 100 person-years in BEAT-AF. Interestingly, we found that rates 
of non-cardiovascular admissions reported in our meta-analysis were very similar to 
the ones shown in our two cohorts. However, in our cohorts there were lower incidence 
rates for cardiovascular admission compared to the ones reported in the meta-
analysis. This observation may be explained by two reasons. First, studies used 
different definitions of cardiovascular hospital admission. For example, events such as 
major or minor bleedings were inconstantly categorized as either cardiovascular or 
non-cardiovascular admission.87 In AF populations, bleedings are events of relative 
frequent occurrence, such that a different categorization of the event may at least partly 
explain the differing incidence rates. Second, in contrast to randomized controlled 
trials, patients who are enrolled in cohort studies may have more medical comorbidities 
and exhibit a lower health status, which may result in higher admission rates. 
Data from large databases in the United States indicate that in individuals aged 
between 45 to 64 years without AF the incidence of any hospital admission is about 
10% per year.88 When looking at the 65 to 84 year olds, the incidence is higher with 
26% per year. Compared to these estimates, in the meta-analysis we showed that AF 
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patients have a 1.6 times higher risk than individuals without the arrhythmia, further 
underscoring the importance admissions in this groups of patients. 
8.1.3. Risk factors for hospital admissions 
Getting knowledge in clinical predictors for hospital admission in AF patients may help 
to identify those who are at highest risk. Increasing age is one of the major risk factors 
associated with hospital admission that is non-modifiable. Several published reports 
have shown that age strongly correlates with the individual admission risk in AF 
patients.49,89 We found similar results, where increasing age was strongly associated 
with higher admission rates, in the meta-regression and also in our cohorts. However, 
age is a strong risk factor for many diseases and adverse outcomes,90 which certainly 
contributes to the increased admission rates. In our meta-analysis we found that 
increasing average age was associated with a higher hospital admission incidence and 
explained some proportion of the observed heterogeneity in meta-regression analysis 
(R2 across 34 studies 15.7%).91 This suggests that age at least in part promotes 
admission risk in this population.   
Among the cardiovascular factors we found that history of diabetes (HR, 1.38) and 
peripheral artery disease (HR, 1.31) were strongly associated with the risk of being 
admitted to the hospital for any cause. Other studies also found similar associations of 
those risk factors with hospital admissions.49,50,89 It has been shown that diabetes and 
prediabetes are strong drivers of hospital admissions, and the risk is proportional to 
higher levels of glycated hemoglobin (HbA1c).92,93 Also, diabetes is an independent 
risk factor of incident AF, further highlighting this interrelationship.6 We found that 
presence of peripheral artery disease strongly correlates with the risk of hospital 
admission. A community-based case-control study showed that 85% of patients with 
peripheral artery disease were hospitalized at least once over e median follow-up of 
5.6 years.94 Also, peripheral artery disease has been known to be associated with the 
risk of AF.95,96 Other than peripheral artery disease, additional important cardiovascular 
risk factors were coronary heart disease, prior stroke/TIA, and heart failure. These 
factors have been strongly linked to AF, and represent important components of the 
CHA2DS2-VASc score, which predicts the risk of stroke in AF patients.97 Patients who 
have a history of coronary heart disease or myocardial infarction are especially prone 
to be admitted to the hospital, mostly for cardiovascular causes, due to heart failure 
and recurrent acute coronary syndrome. Heart failure admission are one of the most 
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important adverse events of patients with AF because they occur frequently and is 
strongly associated with worse prognosis.98 All these factors taken together clearly 
illustrate the high cardiovascular burden that AF patients are exposed to, and each of 
these factors itself adds to the risk of hospital admissions in these patients. These risk 
factors may either be key factors for hospital admissions, or they may also just 
represent the overall frailty level of patients. However, each of these factors is a strong 
predictor for hospital admission in AF patients. Given this, optimal treatment of those 
factors may help to improve patient’s outcomes and subsequently reduce admission 
rates. 
From the non-cardiovascular domain, we found that renal failure, history of cancer and 
previous falls were independently associated with hospital admissions, and the effects 
were even stronger compared to cardiovascular predictors. In Swiss-AF we found that 
the risk of all-cause hospital admission in patients with renal failure was 1.2 times 
higher as compared to patients without renal failure. In ROCKET AF the investigators 
also found a similar association of renal dysfunction with increased hospital admission 
risk.50 In this study impaired renal function, measured by creatinine clearance resulted 
in a hazard ratio of 1.07 (95% CI 1.04–1.10) per 5 unit decrease in creatinine clearance 
below 65 mL/min. Renal function, measured by estimated glomerular filtration rate 
(eGFR), has shown an independent and graded association with hospital admission 
risk, and this risk even increases when patients have concomitant AF.99-101 Renal 
function is particularly important in AF populations given that most AF patients are 
taking an oral anticoagulant, and the risk of bleeding increases with lower renal 
function, particularly when patients are on a direct oral anticoagulant (DOAC). We 
further recognized that history of cancer was among the major non-cardiovascular 
predictors. However, this association is not surprising given that patients who have 
cancer are particularly at great risk of being admitted to the hospital, which has been 
illustrated in several studies.102,103 It can he hypothesized that cancer may be the driver 
for these admission, but there is also evidence that cancer-related treatment such as 
chemotherapy could contribute to the high risk.104 Prior reports have suggested the 
potential interrelationship between cancer and AF.105,106 AF patients with concomitant 
cancer are more likely to be in reduced health status due to cancer but also because 
of coexisting AF. Given the relationship between AF and cancer, those patients are 
particularly at high risk to be admitted in the future. Lastly, we found that previous falls 
strongly predict the risk of future hospital admissions. This is important from two 
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aspects. First, given that a large proportions of AF patients is taking an oral 
anticoagulant, falls can potentially lead to traumatic intracranial bleedings, which is one 
reason why some physicians tend to remove those patients from oral anticoagulation. 
Second, previous falls are a frequent clinical presentation of frailty, which itself is an 
independent predictor for hospital admission. 
Prior history of pulmonary vein isolation (PVI) was inversely associated with hospital 
admissions in the derivation cohort. The HR of patients with previous PVI was 0.7, 
suggesting that those patients who had PVI procedures in the past might have a 30% 
lower risk of future hospital admissions. Several studies have shown the potential effect 
of PVI on readmission and hospital admission rates.107,108 In the Catheter Ablation vs 
Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) trial where AF patients 
were randomized to receive either PVI procedure or conventional antiarrhythmic 
medical therapy, the researchers found that PVI reduces the risk of the composite of 
death and cardiovascular hospital admission.109 However, PVI was not associated with 
a reduction in all-cause mortality, suggesting that the reduction in hospital admissions 
was the strong contributor of this difference in the composite endpoint. The Catheter 
Ablation versus Standard Conventional Therapy in Patients with Left Ventricular 
Dysfunction and Atrial Fibrillation (CASTLE-AF) trial also showed a favorable effect of 
PVI on hospital admission rates in AF patients with concomitant heart failure.110 
However, in this study there was no effect for all-cause hospital admission, which 
stands in contrast to our findings. In BEAT-AF, however, the association between 
catheter ablation and reduction in admission risk could not be confirmed. In both 
cohorts Swiss-AF and BEAT-AF, information on when the procedure was performed 
and whether it was a single procedure or redo ablation was not available. Therefore, it 
remains speculative whether PVI procedures significantly reduce admission rates, 
mainly because there are currently no studies available that sufficiently investigated 
this outcome.    
8.1.4. Risk score for predicting hospital admissions 
We developed the Admit-AF risk score to predict all-cause hospital admission in 
patients with AF. The risk score consists of the predictors that were identified from the 
variable selection method LASSO. These risk predictors were age, prior PVI, 
hypertension, diabetes, coronary heart disease, prior stroke/TIA, heart failure, 
peripheral artery disease, cancer, renal failure, and previous falls. In the derivation 
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cohort (Swiss-AF), the Admit-AF score showed moderate discriminative ability for 1-
year and 3-year admission risk with C statistic of 0.64 and 0.63, respectively. In the 
validation cohort (BEAT-AF), it showed overall lower C statistics of 0.59 for 1- and 3-
years risk prediction of hospital admission. The Admit-AF score was well calibrated in 
Swiss-AF and in BEAT-AF. Although we have been very inclusive and used a broad 
range of variables to build this risk score, the predictive ability was moderate and it 
was even lower in BEAT-AF. There several explanations for this observation. First, the 
outcome all-cause hospital admission is very heterogeneous, including a wide range 
of potential causes for admission. Therefore, to find specific variables that are 
associated with the outcome is complex. Prior studies have also attempted to develop 
risk prediction models for hospital admission, showing somewhat similar discriminative 
ability. For instance, the HOSPITAL score was derived in consecutive patients who 
were discharged from a hospital in the United States.111 In this retrospective cohort, 
17.7% had diagnosed AF based on administrative data. The primary outcome was 30-
day readmission and the HOSPITAL score was developed using multivariable logistic 
regression analysis. The investigators found a high 30-day readmission rate of 22.3%. 
The derived HOSPITAL score consisted of administrative (i.e. length of stay, prior 
oncology service visit, or index type of admission) and laboratory variables (i.e. 
hemoglobin and sodium level at discharge). This score showed a better discriminatory 
performance compared to our Admit-AF score, with a C statistic of 0.71 and it was also 
well calibrated. The HOSPITAL score was then validated in 9 hospitals across 4 
different countries, including one hospital from Switzerland.112 Again, similar predictive 
ability was achieved, with a C statistic of 0.72. However, the C statistic from the hospital 
in Switzerland was lower with 0.68. Although the model was accurately developed in 
this study, the overall discriminatory power was modest with 0.72, and 0.68 for 
Switzerland. Our study showed nearly similar C statistic of 0.64 in AF patients. Taken 
together, these observations underscore the difficulty and challenge to assess this 
heterogenetic outcome of hospital admission. Further, the results indicate that 
although a broad range of variables was used to build the 30-day readmission risk 
HOSPITAL model including laboratory data, it somehow did not achieve enough power 
to predict short-term future admissions. In addition, the outcome in the study where the 
HOSPITAL score was developed, was defined as any readmission within 30 days after 
hospital discharge. Patients how were discharged may have a high risk of being 
readmitted within the next weeks. In contrast, our prediction tool was developed in an 
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outpatient setting, suggesting that the score may be more applicable in patients who 
are seen by their family doctor or general practitioner. Also, it can be speculated that 
the prediction of short-term outcomes may be simpler and easier as compared to long-
term (≥1 year) outcomes, which may reflect the slightly better discriminative ability of 
the HOSPITAL score.  
8.1.5. Psychosocial factors and hospital admissions 
We found that patients who were single or divorced had an increased risk of all-cause 
hospital admission compared to patients who were married. Similar effects of marital 
status on the risk of hospital admission have been observed in non-AF populations, 
suggesting lower admission rates among patients who were married.113,114 This 
confirms the hypothesis that being married may provide a low level of stress and great 
social support. Contrarily, being single or widowed increases emotional stress which 
could result in a higher risk of seeking medical support. Poor health perception is 
common in AF populations, and seems to be poorer in women.115 We showed that 
subjective health evaluations on a VAS scale has an impact on hospital admission risk, 
which was also indicated for cardiovascular and non-cardiovascular admissions. 
Patients who felt in relatively good health conditions were less prone to seek for 
hospital care, indicated by lower admission rates compared to those with lower 
evaluations of health. In other populations such as heart failure patients, patients who 
reported poor or fair health perception had an up to five time higher risk of hospital 
admission or death compared to patients who reported excellent or good health 
perception.116,117 Based on evidence showing that self-efficacy is a key predictor of 
heart failure hospital admission and all-cause death,118 it can be speculated that social 
support and marriage partners may strengthen the patient’s self-efficacy and health-
evaluations, preventing them from hospital admissions. Almost two-third of all hospital 
admissions were for non-cardiovascular reasons. This appears counterintuitive given 
that AF patients are known to have a high burden of cardiovascular comorbidities.25 
AF patients may feel well positioned with regard to their cardiovascular treatment 
strategy and may therefore be more sensitive to non-cardiovascular symptoms and 
disorders. Also, given that most admissions were triggered by non-cardiovascular 
reasons may also point to the involvement of psychosocial factors in this population. 
We also found that when patients single or divorced and showed low heath perception, 
they exhibit a substantial higher risk of hospital admission. This risk gradually 
increased with a higher burden of psychosocial factors. Social support may have a 
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protective impact by keeping patients from the hospital, which suggests that 
considering psychosocial conditions in AF care strategies may be beneficial. Improving 
psychosocial conditions, such as thorough psychotherapy, psychosocial counselling, 
or self-help group assignment, may improve the individual psychosocial situation and 
may foster patient’s resilience and self-efficacy in face of health-related conditions. In 
future studies it would be promising to include direct measures of social support and 
to systematically compare AF treatment with versus without consideration of 
psychosocial support factors. Improvements of psychosocial conditions in AF patients 
may have the potential to contribute to reduced health-care costs arising from hospital 
admissions. 
 
8.2. Methodological aspects 
In order to conduct a prospective multicenter study of a specific patient population is 
challenging and requires not only substantial financial sponsoring, but also a lot of 
technical support and personal efforts. A recent published report indicated that nearly 
25% of all randomized trials in Switzerland had to discontinue prematurely, mainly 
because of recruitment problems and financial difficulties.119 Investigators are 
constantly facing issues and difficulties within the long course of a study. It is not 
enough to have an interesting research question, but feasibility and technical aspects 
are just as important. Therefore, it is not unusual that adjustments of the study protocol 
need to be performed and processes need to be updated in order to continue the study. 
With regard to Swiss-AF we tried to use the most accurate methods currently available 
to address and investigate the research questions that have been raised. Swiss-AF is 
a prospective multicenter cohort study including AF patients that are well-characterized 
and using highly standardized measurements. Also, for each procedure there is 
extensive written standard operating procedure available (SOP), which incorporates 
all important steps in the conduct of a patient visit and examination. These factors were 
implemented with the aim to minimize potential systemic errors, and to enhance the 
quality of the data obtained. However, there remain several aspects that need to be 
discussed in the light of potential limitations. In the following sections, important 
features and potential limitations of the three works will be discussed with regard to 
methodological aspects.  
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8.2.1. Study design and assessment of study variables 
Study design 
Swiss-AF and BEAT-AF are observational cohort studies. Although both studies have 
a prospective design and patients were enrolled based on predefined inclusion criteria, 
causality of the observed associations cannot be proven. In cohort studies, residual 
confounding has always to be taken into account when interpreting presented results. 
However, there are several possibilities to address the issue of confounding. First, 
recruitment strategy of the population of interest should be established appropriately 
to avoid selection bias. This can be done by being inclusive, and avoid a high number 
of exclusion criteria. Also, as for being a community-based cohort study, recruitment 
of patients should focus on different sources, such as hospital, outpatient clinics etc. 
In both cohorts we tried to activate several channels to recruit patients with AF, with 
the intention of having a representative study population from Switzerland. 
Randomized controlled trials usually have strict inclusion and exclusion criteria of 
patients which questions the generalizability of the presented results. Second, 
although the recruitment strategy was chosen appropriately, there are still other 
potential sources of confounding. Patients in Swiss-AF and BEAT-AF were very well 
geno-and phenotyped, which allows us to perform statistical adjustments for the 
relationships being assessed. In the second work we first performed a variable 
selection and subsequently combined the 11 variables found to be associated with 
hospital admission into one multivariable Cox model. In the third work we used 
univariable and multivariable models to test associations of those psychosocial factors 
with hospital admission risk. Covariates used in the multivariable models were the ones 
that were found to be strongly associated with hospital admission from the second 
work. Although we performed several adjustments, residual confounding may still 
persist. Such confounders may be factors the investigators were not aware of or they 
may be factors which simply haven’t been measured in the study. Through technical 
improvements in genetic engineering methods, additional opportunities for accounting 
residual confounding have opened up. Mendelian randomization has been proposed 
as a method to overcome some of the residual confounding.120,121 This method uses 
measured variations in genes of known function to investigate the potential causal 
effect of an exposure on the development of a disease or outcome. Social or behavioral 
confounding factors are particularly difficult to measure accurately and difficult to 
control for in analyses. Mendelian randomization allows to test for a causal effect from 
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observational data in the presence of confounding factors by using common genetic 
polymorphism with known effects. Nonetheless, whether the use of genetic information 
will add to population-based research needs to be evaluated and confirmed in the 
future. Also, how these results can be transferred into clinical practice has to be 
investigated. 
Assessment of clinical variables and hospital admissions  
In the Swiss-AF study, several demographic and clinical characteristics were obtained 
from all patients included in the study. Information in demographic parameters was 
collected using standardized case report forms (CRF). Several large cohort studies 
have used a similar approach to perform broad data collection of enrolled patients. For 
instance, in the Framingham Heart Study, the investigators use a 44-page CRF to 
collect information about all important variables that can be directly obtained during a 
patient visit. The design and formatting of the CRF allows the examiner to choose and 
tick prespecified answers, which enhances overall data quality and reduces free text 
options. During yearly follow-up visits, patients enrolled in Swiss-AF were reassessed 
for medical information, comorbidities and blood sampling. This enables us to capture 
temporal fluctuations of important variables, which helps us to better understand 
associations between certain exposures and the outcome in the population. 
In the second and third work the primary outcome was all-cause hospital admission. In 
Swiss-AF, we used a section in the CRF where patients were asked whether they had 
an unplanned hospital admission within the last year. However, this outcome was not 
centrally adjudicated or validated. As this is an outcome that usually occurs often in a 
population of the elderly individuals, a central adjudicated event assessment would 
have increased the quality of the admission events. Furthermore, although the CRF 
allows the investigator to distinguish whether the patient had experienced a 
cardiovascular or a non-cardiovascular admission, further information in the admission 
event was not systematically collected. Therefore, information on cause-specific 
admissions were not available. This additive information would certainly allow to better 
understand the underlying causes for admissions and may point to additional risk 
factors for hospital admissions. Also, information on the length-of-stay of in the hospital 
was not collected in both studies. Several reports have been published indicating that 
the individual length-of-stay (LOS) of a patient in the hospital strongly correlates with 
outcomes in the future. For instance, an analysis using administrative data from the 
Global Comparators Project from 26 hospitals on patients discharged from the hospital 
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between 2007 and 2012 including showed that patients who were in the upper quartile 
of LOS had a higher odds of death compared to those who were in the lowest quartile 
of LOS.122 Reports from heart failure populations indicated similar results, whereas 30-
day mortality risk was highest after long LOS.123 Interestingly, this study demonstrated 
a U-shaped relationship between LOS and cardiovascular and non-cardiovascular 
readmissions, with higher rates in patients who had a short LOS or a long LOS. It is 
unclear how LOS affects admission rates in AF patients, and so far no study has 
addressed this question. 
8.2.2. Statistical analysis 
Meta-analysis 
In the first study we performed a meta-analysis of studies that reported the incidence 
of hospital admissions. After extensive literature reviewing, we pooled the collected 
data using random effects meta-analysis. The advantage of this type of review is that 
it can be completed relatively quickly, it is low-cost and most of the data is relatively 
easy to access. However, several statistical aspects need to be discussed. From the 
studies that were deemed eligible for quantitative synthesis in our meta-analysis, we 
recognized that incidence rates were not always reported appropriately. To allow us to 
pool the data we had to calculate the incidence rates from the information available 
using Poisson distribution. We checked for the validity of our models by comparing the 
calculated incidences with the ones reported in studies with this information available. 
We found that the calculated incidence rates were similar to those reported in the 
studies. Prior meta-analyses have used a similar approach,124 indicating that this 
approach is valid to use. Nevertheless, the calculated estimates reported in our meta-
analysis may differ from the true incidence rates and this should be taking into account 
when interpreting the results.  
Another important limitation of the meta-analysis is that the results of the study are 
based on aggregated published data and does not include individual patient-level data. 
This method is susceptible to publication bias, researchers usually have limited control 
over the data and the interpretation of the summary estimates has to be done in the 
context of between-study heterogeneity. This heterogeneity often arises as a result 
from different study designs, study populations, model selections and analyses, and 
categorization of variables in the original studies. In order to address this issue we 
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used random effects models which accounts for the anticipated high level of between-
study heterogeneity.  
Variable selection  
In the second manuscript we used predictors associated with hospital admissions to 
establish a new risk prediction model. We used a variable selection method that 
accurately selected the appropriate variables, which then could be entered on the 
prediction model. The variable selection method called least absolute shrinkage and 
selection operator (LASSO) is a linear regression analysis that simultaneously 
performs variable selection and regularization by using machine learning algorithms.69 
All candidate variables available in Swiss-AF and BEAT-AF were included in one 
model, LASSO performed regression analyses, and shrinked the absolute size of the 
regression coefficients towards zero. This shrinkage is achieved by placing a penalty 
to the summation of the regression coefficients of the variables included. Therefore, 
variables with regression coefficients that shrink to zero are eliminated. The variables 
most strongly associated with the outcome remain in the final model. This method has 
been introduced many years ago, and it has been used in several publications where 
variable selection and model development was performed.125,126 The advantage is that 
it operates completely independent and is not influenced by the investigator’s 
preferences in choosing the optimal set of variables for the model. LASSO has total 
control over the selection process and does not add any subjective modifications. 
There is another advantage which LASSO has over conventional model development 
strategies, such as backward or forward variable selection. Because LASSO shrinks 
the regression coefficients of the variables towards zero, it not only keeps the most 
powerful predictors, but it also builds a highly robust and simple model. Also, 
conventional regression analysis usually produces models that tend to be overfitted. 
By adding a penalization to the regression coefficients, LASSO produces a robust 
model, which can be applied in other populations. Potential limitation of this method is 
that it only works with those variables that are entered into the program. Therefore, in 
order to find the most strongly associated predictors for the outcome of interest, it is 
important to include a broad range of different variables. Also, it is possible that LASSO 
produces a model including variables which may be difficult to obtain in clinical 
practice, which limits its practicability. This is why the model selection process should 
always incorporate variables which are simple to collect in order to maximize the 
usability of the prediction tool. 
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Risk scoring system 
We build a point-based risk scoring system for unplanned hospital admissions by using 
the regression coefficients from the model. This method has been proposed because 
it adds weights coefficients of the predictors, which enhances the model performance 
substantially.127 This technique has been used extensively, and several reports have 
shown that the risk score can be implemented appropriately.128,129 The risk score 
achieved a C statistic of 0.64 in the derivation and a C statistic of 0.59 in the validation 
cohort. Although the model was well calibrated in the derivation and also in the 
validation cohort, it showed moderate discriminative ability to predict future hospital 
admissions. Although this technique adds weights to points based on regression 
coefficients, it may not be completely represent the overall weight of each predictor. In 
example, hypertension did not fully reach statistical significance in the multivariable 
model. When applying the point-based scoring system, this variable received the same 
amount of points as the variable coronary heart disease, which was statistical 
significant in the multivariable model. Thus, both variables were similarly weighted, 
although only history of coronary heart disease was significantly associated. 
Nevertheless, it is reasonable to include non-significant variables into the model, as 
non-significance may not necessary mean that there is no evidence for an effect of the 
predictor, which is indicated by the regression coefficient.130 This issue should be a 
matter of debate and biological plausibility.   
 
8.3. Relevance and future implications 
8.3.1. Relevance of the study 
We showed based on data from our meta-analysis that the incidence of hospital 
admission in AF patients is high. Results from out cohorts suggested that several 
cardiovascular and non-cardiovascular factors are associated with an increased risk of 
admission, also including psychosocial factors. These findings underscore the 
importance that detailed risk assessment and implementation of focused treatment 
strategies in AF patients should be a key priority for physicians and health care 
providers. Based on our data available we established a new risk score for accurately 
predicting long-term admission risk. We suggest that this score is a first step towards 
preventive approaches to reduce rates of unnecessary hospital admissions in AF 
populations. The score was successfully validated in another external AF cohort, but 
further analyses are needed to further assess the practicability of this score in 
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identifying high risk patients. Public health organizations and policy makers should give 
efforts to establish preventive programs to reduce unnecessary admissions in this 
vulnerable population. Together such strategies will not only have an impact on the 
patients outcome, but they may also help reducing health care expenditures.  
8.3.2. Future implications and outlook 
The three presented works show that hospital admissions is a problem in AF patients, 
and there are no strategies available to reduce these admission rates appropriately. 
Swiss-AF and BEAT-AF are both ongoing cohort studies. In the future we will be able 
to assess the long-term consequences of hospital admissions in AF, and investigate 
whether risk factors for admission change over time. In the second work we found that 
several cardiovascular and non-cardiovascular factors were associated with a higher 
admission risk. Given this information, new research questions and projects should 
focus on optimizing treatment in AF patients in a broader way. This could mean that a 
complementary treatment strategy, which includes risk factors assessment, 
individualized patient-specific therapy and psychosocial counselling and advisory. As 
mentioned, we also found that psychosocial factors predict hospital admissions. This 
finding highlights that apart from conventional risk factors, there are other mechanisms 
that may influence the overall risk of patients for being admitted to the hospital. Being 
single or divorced, or having low health perception are important factors for hospital 
admissions. Given these findings, additional factors may also contribute to this high 
admission risk in AF population. Future studies should address the question whether 
factors such as social support may provide insights in the overall wellbeing of a patient. 
In addition, studies are needed that investigate if cultural differences and household 
income discrepancies may add to the risk of admission. Also, it could be assessed 
whether there are significant differences in admission rates between patients 
depending on their living environment (rural versus urban). 
In the future, we are planning to conduct a randomized trail within our cohort Swiss-AF 
to assess the effect of an integrated AF-care system on hospital admissions and other 
adverse outcomes in those patients.131,132 The hypothesis is that a comprehensive 
integrated AF-care system within the heath care facility incorporating trained AF 
specialists and nurses who can intervene in those situations where AF patients might 
seek health care. This AF care system could consist of cardiovascular risk factor and 
lifestyle counseling, nurse-guided patient training, guideline-based optimization of 
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medical treatment and tele medical patient assistance via a 24/7 AF helpline in addition 
to routine standard care has the potential to develop favorable effects on outcome and 
ambulatory contacts and hospital admissions. AF patients could receive a booklet on 
the management of AF and related risk factors and additional group training session, 
which covers general behavioral, AF-specific and self-management trainings. 
Furthermore, patients may visit a trained nurse, who performs a detailed review of the 
cardiovascular risk factors, lifestyle habits (blood pressure, weight, smoking, physical 
activity) and the completion of questionnaires on drug adherence and anxiety, followed 
by a detailed discussion about the personal goals and possible strategies for a change 
in habits. This may help to optimize the patient’s individual treatment strategy, and 
subsequently reduce adverse outcomes.133 Also, 24/7 AF helpline could be offered to 
inform and help AF patients who are feel in health distress. All these potential 
interventions could result in substantial reduction of unplanned hospital admissions. 
 
8.4. Conclusions 
Patients with AF are highly vulnerable populations for adverse outcomes. We 
assessed the overall incidence of hospital admissions, identified risk factors associated 
with admissions patients with AF and developed a prediction tool to predict the risk of 
future hospital admissions. Based on the high incidence and the strong associations 
of several risk factors with hospital admissions, we suggest an interrelationship 
between the burden of risk factors and hospital admissions. Because there are many 
different factors associated with hospital admissions, including cardiovascular but also 
non-cardiovascular factors, this risk can only be tackled when taking into account the 
overall comorbidity burden of the individual patient. Therefore it is assumable that new 
preventive strategies that aim to reduce admission should incorporate a multi-factorial 
approach. The results presented in this research work can be taken to develop new 
research questions to further explore in depth the underlying causes for hospital 
admissions and to establish preventive strategies that may help to reduce these rising 
admission rates and improve outcomes in patients with diagnosed AF. 
  
155 
 
8.5. Specific contributions by the PhD student 
After the successful application for the PhD program in clinical research, I have been 
introduced to the Swiss-AF and BEAT-AF cohort and the study team. The study team 
consisting of study coordinators and MD students provided me a detailed introduction 
in the conduct and processes of the two cohort studies. By then, I was fully engaged 
with daily routines of Swiss-AF by spending a lot of time in actively recruiting new 
patients for the study and performed many study visits, which mostly consisted of 
taking a medical history, performing physical examinations, neurocognitive tests and 
performing electrocardiogram recording. Also, I took over the planning follow up visits 
within the cohort and started to work on my research proposal. During this intensive 
writing period, I’ve gained valuable knowledge from the development of the research 
hypothesis to the structuring and writing of a full research proposal. During that 
important time, I regularly reviewed current scientific literature on AF in general and 
especially on hospital admissions in AF to further specify my research question and to 
prepare my systematic review. During the second and third PhD years I learned a lot 
about how to compute and perform statistical analyses using Stata. For the meta-
analysis I performed the data collection, data management and performed the 
statistical analysis. For the second and third paper I performed the LASSO variable 
selection process and computed all the statistical models using the same statistical 
software.  
During my PhD time, I actively participated in weekly Journal Clubs at the 
Cardiovascular Research Institute Basel (CRIB), where residents and research fellows 
of the Department of Cardiology presented the newest research data or their our own 
work. Also, I participated in the weekly study meetings. After gaining some knowledge 
in the conduct of meta-analysis, I got the opportunity to assist research fellow in the 
conduct of meta-analyses outside of my PhD project. 
Furthermore, I got the opportunity to present my research work on several national 
(Joint Annual Meeting of the Swiss Society of Cardiology) and international (European 
Society of Cardiology) scientific conferences. Also, I got the opportunity to be part of 
the Swiss-AF sub-study called Swiss-AF Burden by contributing in the design and 
implementation of the study. Together with the team, I wrote a standard operating 
procedure for the scientific evaluation of the 7-day Holter electrocardiogram 
recordings. During the course of my PhD, I was more and more involved in the 
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supervision of doctoral students and Masters students. I provided methodological and 
statistical assistance to the doctoral students and supervised Masters students in their 
daily work in our research group.  
Overall, I can say that I have learned many important aspects during my time as a PhD 
student. I was able to gain a lot of knowledge in health research methodology, data 
analysis and scientific writing by direct teaching from my supervisors as well as through 
close collaboration with other excellent researchers and epidemiologists outside from 
our research group and from international experts.  
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